EMAGIN CORPORATION Form DEF 14A
SCHEDULE
14A
(RULE
14a-101)
INFORMATION
REQUIRED IN PROXY STATEMENT
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of the Securities
Exchange
Act of 1934 (Amendment No. )
Filed
by
the Registrant [X]
Filed
by
a Party other than the Registrant [_]
Check
the
appropriate box:
[
]
Preliminary Proxy Statement
|
[_]
Confidential, For Use of the Commission Only
(As
Permitted by Rule 14a-6(e)(2))
|
[ X]
|
Definitive
Proxy Statement
|
[_]
|
Definitive
Additional Materials
|
[_]
|
Soliciting
Material Pursuant to Rule 14a-11(c) or Rule
14a-12
|
EMAGIN
CORPORATION
(Name
of
Registrant as Specified In Its Charter)
(Name
of
Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
[_]
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
(1)
|
Title
of each class of securities to which transaction
applies:
|
(2)
|
Aggregate
number of securities to which transaction
applies:
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant
to
Exchange Act Rule 0-11 (set forth the amount
on
which the filing fee is calculated and state how it was
determined):
|
(4)
|
Proposed
maximum aggregate value of
transaction:
|
[_]
|
Fee
paid previously with preliminary
materials.
|
[_]
Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or
the form or schedule and the date of its filing.
(1)
|
Amount
Previously Paid:
|
(2)
|
Form,
Schedule or Registration Statement
No.:
|
eMagin
Corporation
2006
NOTICE
OF ANNUAL MEETING
AND
PROXY
STATEMENT
_____________________
Friday,
October 20, 2006
at
2:00 pm
_____________________
Hyatt
Bellevue
900
Bellevue Way N.E.
Bellevue,
Washington, 98004
IMPORTANT
The
return of your signed Proxy as promptly as possible will greatly
facilitate arrangements for the Annual Meeting. No postage is required
if
the Proxy is returned in the envelope enclosed for your convenience
and
mailed in the United States. If you received a proxy card with a
website
address and voting codes, we urge you to vote on the Internet
at http://proxy.georgeson.com
or telephonically at 1-800-790-3272, to ensure that your vote is
recorded
without mail delays. If you vote by telephone or the Internet
you do not need to return the proxy card.
|
eMagin
Corporation
10500
NE
8th
Street
Suite
1400
Bellevue,
WA 98004
September
21, 2006
Dear
Stockholder:
You
are
cordially invited to attend the 2006 Annual Meeting of Stockholders (the
“Meeting”) of eMagin Corporation, which will be held at the Hyatt Bellevue, 900
Bellevue Way N.E., Bellevue, Washington, 98004 on Friday, October 20, 2006,
at
2:00 pm local time. Details of the business to be conducted at the Meeting
are
provided in the attached Notice of Annual Meeting and Proxy
Statement.
Whether
or not you plan to attend the Meeting, it is important that your shares be
represented and voted at the Meeting. Therefore, we urge you to vote your shares
as soon as possible. Instructions in the proxy card will tell you how to vote
over the Internet, by telephone, or by returning your proxy card by mail. The
proxy statement explains more about proxy voting. Please read it
carefully.
We
highly
encourage you to receive future eMagin annual reports and proxy statement
materials electronically and help us save costs in producing and distributing
these materials. If you wish to receive our annual report and proxy statement
electronically next year, please follow the instructions on the enclosed proxy
card.
Beginning
at 1:00 pm, prior to commencement of the meeting, we will provide interactive
demonstrations of some of our exciting microdisplay products as well as several
products being commercialized by our customers. If you would like to participate
in this event, please arrive by 1:30 pm to allow time for viewing the
exhibit.
We
look
forward to meeting those of you who will be able to attend the Meeting, and
appreciate your continued support of our company.
Sincerely,
/s/
Thomas Paulsen
Thomas
Paulsen
Chairman
of the Board of Directors
|
|
/s/
Gary W. Jones
Gary
W. Jones
Chief
Executive Officer and President
|
|
|
|
|
|
eMagin
Corporation
NOTICE
OF ANNUAL MEETINGS OF STOCKHOLDERS
TO
BE HELD ON October 20, 2006
To
our Stockholders:
The
2006
Annual Meeting of Stockholders (the “Annual Meeting”) of eMagin Corporation
(“eMagin” or the “Company”) will be held at the Hyatt Bellevue, 900 Bellevue Way
N.E., Bellevue, Washington, 98004, on Friday, October 20, 2006, at 2:00 pm
local
time, to consider the following proposals:
|
1. |
To
elect 3 directors to the Company's Board of Directors, to hold
office for
terms of three (3) years and until their successors are duly elected
and
qualified or until their earlier resignation or removal (Proposal
No.
1)
|
|
2. |
To amend the Company's certificate
of
incorporation to increase the maximum number of directors which may
be
appointed to the Company’s Board of Directors from 9 to 10 persons
(Proposal No. 2) |
|
3. |
To authorize the Company's Board
of Directors,
in its discretion, to amend the Company's certificate of incorporation
to
effect a reverse stock split of the outstanding shares of the Company's
common stock at a ratio of one-for-ten (Proposal No.
3) |
|
4. |
To consider the approval of the potential
issuance of shares of our common stock underlying our 6% Senior Secured
Convertible Notes Due 2007-2008 and warrants to purchase shares of
our
common stock at a price below fair market value (Proposal No.
4) |
|
5. |
To increase the number of authorized
shares of
common stock issuable pursuant to the 2004 Non-Employee Stock Compensation
Plan from 2,000,000 to 9,500,000 shares (Proposal No.
5) |
|
6. |
To ratify the appointment of Eisner
LLP as the
Company’s independent auditors for the fiscal year ending December 31,
2006 (Proposal No. 6) |
|
7. |
To
consider and transact such other business as may properly come before
the
Annual Meeting and any adjournment or postponement
thereof. |
BECAUSE
OF THE SIGNIFICANCE OF THESE PROPOSALS TO THE COMPANY AND ITS SHAREHOLDERS,
IT
IS VITAL THAT EVERY SHAREHOLDER VOTES AT THE ANNUAL MEETING IN PERSON OR BY
PROXY.
These
proposals are fully set forth in the accompanying Proxy Statement, which you
are
urged to read thoroughly. For the reasons set forth in the Proxy Statement,
your
Board of Directors recommends a vote "FOR" each of the proposals. The Company
intends to mail the Annual Report, Proxy Statement and Proxy enclosed with
this
notice on or about September 21, 2006, to all stockholders entitled to vote
at
the Annual Meeting. If you were a stockholder of record of eMagin common stock
(AMEX:EMA) on September 21, 2006, the record date for the Annual Meeting, you
are entitled to vote at the meeting and any postponements or adjournments of
the
meeting. Shareholders are cordially invited to attend the Annual Meeting.
However, whether or not you plan to attend the meeting in person, your shares
should be represented and voted. After reading the enclosed Proxy Statement,
please sign, date, and return promptly the enclosed proxy in the accompanying
postpaid envelope we have provided for your convenience to ensure that your
shares will be represented. Alternatively, you may wish to provide your response
by telephone or electronically through the Internet by following the
instructions set out on the enclosed Proxy card. If you do attend the meeting
and wish to vote your shares personally, you may revoke your Proxy.
Admission
to the Annual Meeting will be by ticket only. If you are a registered
stockholder planning to attend the meeting, please check the appropriate box
on
the Proxy card and retain the bottom portion of the card as your admission
ticket. Registration will begin at 1:00 p.m., and seating will begin at 1:30
p.m. A product exhibit will be available beginning at 1:00 p.m. and concluding
at 1:50 p.m. Stockholders holding stock in brokerage accounts (“street name”
holders) will need to bring a copy of a brokerage statement reflecting stock
ownership as of the record date. Cameras, recording devices, and other
electronic devices will not be permitted at the meeting. We thank you for your
cooperation in returning your proxy as promptly as possible.
By
Order
of the Board of Directors
/s/
Susan
K. Jones
Susan
K.
Jones
Executive
Vice President and Secretary
TABLE
OF CONTENTS
|
Page
|
|
1
|
What
is the purpose of the Annual Meeting?
|
1
|
Who
is entitled to vote at the meeting?
|
1
|
Who
can attend the meeting?
|
1
|
Why
is the Company soliciting proxies?
|
2
|
What
constitutes a quorum?
|
2
|
How
do I vote?
|
2
|
Can
I vote by telephone or electronically?
|
2
|
Can
I change my vote after I return my Proxy card?
|
2
|
What
are the Board’s recommendations?
|
3
|
What
vote is required to approve each item?
|
3
|
INFORMATION
ABOUT STOCK OWNERSHIP
|
4
|
How
much stock is owned by 5% stockholders, directors, and executive
officers
|
4
|
INFORMATION
ABOUT THE BOARD OF DIRECTORS
|
6
|
How
often did the Board meet during fiscal 2005?
|
6
|
What
committees has the Board established?
|
6
|
How
are directors compensated?
|
8
|
INFORMATION
ABOUT THE EXECUTIVE OFFICERS
|
8
|
Executive
Compensation
|
9
|
What
is the Company’s philosophy of executive officer
compensation
|
9
|
Report
of the Compensation Committee of the Board of
Directors
|
9
|
Aggregated
Option Exercises in Last Fiscal Year and Fiscal Year-End Option
Value
|
12
|
Executive
Employment
Agreements
|
12
|
Report
of the Audit Committee of the Board of Directors
|
13
|
Certain
relationships and related transactions
|
14
|
ACTIONS
TO BE TAKEN AT THE MEETING
|
16
|
ITEM
1—ELECTION OF CLASS B DIRECTORS
|
16
|
ITEM
2—
AMENDMENT TO INCREASE NUMBER OF MAXIMUM BOARD MEMBERS
|
20
|
ITEM
3—
APPROVAL OF THE REVERSE STOCK SPLIT
|
21
|
ITEM
4—
APPROVAL OF POTENTIAL ISSUANCE OF SHARES BELOW FAIR MARKET VALUE
|
27
|
ITEM
5—
INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK ISSUABLE
PURSUANT
TO THE 2004 NON-EMPLOYEE STOCK
COMPENSATION
PLAN
|
28
|
|
|
ITEM
6—RATIFICATION
OF THE APPOINTMENT OF INDEPENDENT AUDITORS
|
31
|
OTHER
MATTERS
|
32
|
ADDITIONAL
INFORMATION
|
32
|
APPENDIX
A - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
|
33
|
APPENDIX
B - AMENDED AND RESTATED 2004 NON-EMPLOYEE COMPENSATION PLAN
|
39
|
IMPORTANT:
Please immediately SIGN, DATE, and RETURN the enclosed Proxy or
submit
your Proxy by telephone or the Internet, whether or not you plan
to attend
the Annual Meeting. A return envelope, which requires no postage
if mailed
in the United States, is enclosed for your convenience.
|
eMagin
Corporation
10500
NE 8th
Street, Suite 1400
Bellevue,
WA 98004
(425)
749-3600
______________________
PROXY
STATEMENT
_______________________
This
Proxy Statement is furnished in connection with the solicitation of proxies
by
the Board of Directors of eMagin Corporation (“eMagin” or the “Company”) to be
voted at the Annual Meeting of stockholders which will be held at the Hyatt
Bellevue on Friday, October 20, 2006, at 2:00 p.m., and at any postponements
or
adjournments thereof.
INFORMATION
ABOUT THE ANNUAL MEETING AND VOTING
At
our
Annual Meeting, stockholders will act upon the matters outlined in the Notice
of
Annual Meeting on the cover page of this Proxy Statement, including (i) the
election of Class B directors, (ii) amending the Certificate of Incorporation
to
increase the maximum number of directors which may be appointed to the Company’s
Board of Directors from 9 to 10 persons, (iii) authorizing the Board of
Directors, in its discretion, to amend the Certificate of Incorporation to
effect the reverse stock split, (iv) approving of the potential issuance of
shares of our common stock underlying our 6% Senior Secured Convertible Notes
Due 2007-2008 and warrants to purchase shares of our common stock, at a price
below fair market value, (v) increasing the number of authorized shares of
common stock issuable pursuant to the 2004 Non-Employee Stock Compensation
Plan
from 2,000,000 to 9,500,000 shares, and (vi) ratification of the appointment
of
the Company’s independent auditors. In addition, management will report on the
performance of the Company during fiscal year 2006 and respond to questions
from
stockholders.
Stockholders
of record at the close of business on September 21, 2006, the record date for
the meeting, are entitled to receive notice of and to participate in the Annual
Meeting. As of the record date, the Company had outstanding and entitled to
vote
101,316,118 shares of common stock. The common stock is the only class of stock
of eMagin that is outstanding and entitled to vote at the Annual Meeting. If
you
were a stockholder of record of common stock on that record date, you will
be
entitled to vote all of the shares that you held on that date at the meeting,
or
any postponements or adjournments of the meeting. Each outstanding share of
eMagin common stock will be entitled to one vote on each matter. Stockholders
who own shares registered in different names or at different addresses will
receive more than one Proxy card. You must sign and return each of the Proxy
cards received to ensure that all of the shares owned by you are represented
at
the Annual Meeting.
Only
stockholders as of the record date, or their duly appointed proxies, may attend
the meeting, and each may be accompanied by one guest. Seating, however, is
limited. Admission to the meeting will be on a first-come, first-served basis.
Registration and product demonstrations will begin at 1:00 pm., and seating
will
begin at 1:30 pm. Cameras, recording devices and other electronic devices will
not be permitted at the meeting.
You
will need an admission ticket to enter the meeting.
For
registered stockholders, the bottom portion of the Proxy card enclosed with
the
Proxy Statement is their Annual Meeting admission ticket. Beneficial owners
with
shares held in “street name” (that is, through an intermediary, such as a bank
or broker), should request tickets in writing from Investor Relations, eMagin
Corporation, 10500 NE 8th
Street,
Suite 1400, Bellevue, WA 98004 (or by facsimile to 425-749-3601) and include
proof of ownership, such as a copy of a bank or brokerage firm account statement
or a letter from the broker, trustee, bank or nominee holding their stock,
confirming beneficial ownership. Please note that if you hold your shares in
“street name” you will need to bring a copy of a brokerage statement reflecting
your stock ownership as of the record date and check in at the registration
desk
at the meeting.
Because
many of our stockholders are unable to personally attend the Annual Meeting,
the
Board of Directors of eMagin (the “Board” or the “Board of Directors”) solicits
the enclosed proxy so that each stockholder is given an opportunity to vote.
This proxy enables each stockholder to vote on all matters which are scheduled
to come before the meeting. When the Proxy is returned properly executed, the
stockholder's shares will be voted according to the stockholder's directions.
Stockholders are urged to specify their choices by marking the appropriate
boxes
on the enclosed Proxy card.
The
presence at the meeting, in person or by proxy, of the holders of a majority
of
the number of shares of common stock issued and on the record date will
constitute a quorum permitting the meeting to conduct its business. As noted
above, as of the record date, 101,316,118 shares of eMagin common stock,
representing the same number of votes, were outstanding. Thus, the presence
of
the holders of common stock representing at least 50,658,060 votes will be
required to establish a quorum.
For
your
convenience, eMagin is offering you four methods of voting.
·
|
You
may indicate your vote on the enclosed proxy card, sign and date
the card,
and return the card in the enclosed prepaid
envelope.
|
·
|
You
may vote by telephone by calling the toll free number that appears
on the
enclosed proxy card and following the instructions
given.
|
·
|
You
may vote via the Internet by following the instructions provided
on the
enclosed proxy card.
|
·
|
You
may attend the meeting and vote in
person.
|
All
shares entitled to vote and represented by a properly completed and executed
proxy received before the meeting and not revoked will be voted at the meeting
as you instruct in a proxy delivered before the meeting. If you do not indicate
how your shares should be voted on a matter, the shares represented by your
properly completed and executed proxy will be voted as the Board of Directors
recommends on each of the enumerated proposals and with regard to any other
matters that may be properly presented at the meeting and all matters incident
to the conduct of the meeting. If you are a registered stockholder and attend
the meeting, you may deliver your completed Proxy card in person. "Street name"
stockholders who wish to vote at the meeting will need to obtain a proxy form
from the institution that holds their shares. All votes will be tabulated by
the
inspector of election appointed for the meeting, who will separately tabulate
affirmative and negative votes, abstentions and broker non-votes.
Can
I vote by telephone or electronically?
If
you
are a registered stockholder (that is, if you hold your stock in certificate
form), you may vote by telephone, or electronically through the Internet, by
following the instructions included with your Proxy card. If your shares are
held in “street name,” please check your Proxy card or contact your broker or
nominee to determine whether you will be able to vote by telephone or
electronically. Please follow the voting instructions on the enclosed proxy
card.
The
deadline for voting by telephone or electronically is 5:00 p.m. (Eastern
Standard Time) on October 19, 2006.
A
Proxy
may be revoked by giving the Secretary of eMagin written notice of revocation
at
any time before the voting of the shares represented by the Proxy. A stockholder
who attends the meeting may revoke a Proxy at the meeting. Attendance at the
meeting will not, by itself, revoke a Proxy.
Abstentions
and broker non-votes.
While
the inspectors of election will treat shares represented by Proxies that reflect
abstentions or include "broker non-votes" as shares that are present and
entitled to vote for purposes of determining the presence of a quorum,
abstentions or "broker non-votes" do not constitute a vote "for" or "against"
any matter and thus will be disregarded in any calculation of "votes cast."
However, abstentions and "broker non-votes" will have the effect of a negative
vote if an item requires the approval of a majority of a quorum or of a
specified proportion of all issued and outstanding shares.
Unless
you give other instructions on your Proxy card, the persons named as proxy
holders on the Proxy card will vote in accordance with the recommendations
of
the Board of Directors. The Board’s recommendation is set forth together with
the description of each item in this Proxy Statement. In summary, the Board
recommends a vote:
·
|
for
election of the nominated slate of Class B
directors
|
·
|
for
amending to the Company's certificate of incorporation to increase
the
maximum number of directors which may be appointed to the Company’s Board
of Directors from 9 to 10 persons
|
·
|
for
authorizing the Company's Board of Directors, in its discretion,
to amend
the Company's certificate of incorporation to effect a reverse stock
split
of the outstanding shares of the Company's common stock at a ratio
of
one-for-ten
|
·
|
for
approving
of the potential issuance of shares of our common stock underlying
our 6%
Senior Secured Convertible Notes Due 2007-2008 and warrants to purchase
shares of our common stock, at a price below fair market
value
|
|
|
·
|
for
increasing the number of authorized shares of common stock issuable
pursuant to the 2004 Non-Employee Stock Compensation Plan from 2,000,000
to 9,500,000 shares
|
·
|
for
ratification of the appointment of Eisner LLP as the Company’s independent
auditors for fiscal year 2006
|
With
respect to any other matter that properly comes before the meeting, the proxy
holders will vote as recommended by the Board of Directors or, if no
recommendation is given, in their own discretion.
The
election of the directors of the Company requires the affirmative vote of a
plurality of the votes cast by stockholders at the Annual Meeting. A properly
executed Proxy marked “WITHOLD AUTHORITY” with respect to the election of one or
more directors will not be voted with respect to the director or directors
indicated, although it will be counted for the purposes of determining whether
there is a quorum.
Approving
of the potential issuance of shares of our common stock underlying our 6% Senior
Secured Convertible Notes Due 2007-2008 and warrants to purchase shares of
our
common stock, at a price below fair market value, authorizing the Company's
Board of Directors, in its discretion, to amend the Company's certificate of
incorporation to effect a reverse stock split, increasing the number of
authorized shares of common stock issuable pursuant to the 2004 Non-Employee
Stock Compensation Plan, and ratification of the appointment of Eisner LLP
as
the Company's independent auditors for fiscal year 2006, will each require
the
affirmative vote of the holders of at least a majority of the shares of common
stock present in person or represented by proxy and entitled to vote at the
Annual Meeting. Approving of the amendment to the Company's certificate of
incorporation to increase the maximum number of directors which may be appointed
to the Company’s Board of Directors from 9 to 10 persons requires the
affirmative vote of the holders of at least 66 2/3% of the shares of common
stock present in person or represented by proxy and entitled to vote at the
Annual Meeting.
INFORMATION
ABOUT STOCK OWNERSHIP
The
following table sets forth the number of shares known to be owned by all persons
who own at least 5% of eMagin’s outstanding common stock, the Company’s
directors, the executive officers named in the summary “Annual Compensation”
table on page 12, and the directors and executive officers as a group as of
August 21, 2006, unless otherwise noted. Unless otherwise indicated, the
stockholders listed in the table have sole voting and investment power with
respect to the shares indicated.
Name
of Owner
|
Common
Stock
Beneficially
Owned
|
Percentage
Beneficial
Common
Stock**
|
Stillwater
LLC (1)
|
18,395,867
|
14.5%
|
George
Haywood
|
6,763,288
|
5.7%
|
Ginola
Limited (2)
|
19,102,868
|
14.6%
|
Gary
W. Jones (3)
|
5,767,893
|
4.8%
|
Susan
K Jones (3)
|
5,767,893
|
4.8%
|
Rainbow
Gate Corporation (4)
|
8,048,212
|
6.8%
|
Ogier
Trustee (Jersey) Limited (5)
|
976,200
|
*
|
Paul
Cronson (6)
|
407,657
|
*
|
Claude
Charles (7)
|
110,000
|
*
|
John
Atherly (8)
|
4,160
|
*
|
Jack
Goldman (9)
|
0
|
0%
|
Thomas
Paulsen, RADM, USN (ret.) (10)
|
0
|
0%
|
Dr.
Jill Wittels (11)
|
0
|
0%
|
Irwin
Engelman (12)
|
0
|
0%
|
Stephen
Seay, Brig. General, U.S. Army (ret.) (13)
|
0
|
0%
|
Dr.
Radu Auf der Heyde (14)
|
1,451,217
|
*
|
All
executive officers and directors as a group (consisting of 11
individuals)
(15)
|
7,740,827
|
6.5%
|
*
Less
than 1% of the outstanding common stock
**
Beneficial Ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or investment
power with respect to securities. Shares of common stock subject to options
or
warrants currently exercisable or convertible, or exercisable or convertible
within 60 days of August 21, 2006, are deemed outstanding for computing the
percentage of the person holding such option or warrant but are not deemed
outstanding for computing the percentage of any other person. Percentages are
based on a total of 118,774,843 shares of common stock outstanding on August
1,
2006, and the shares issuable upon the exercise of options and warrants
exercisable on or within 60 days of August 21 2006, as described
below.
(1)
This
figure represents: (i) 10,235,236
shares
owned by Stillwater LLC, which includes 2,628,417
shares
owned by Rainbow Gate Corporation, in which the sole member of Stillwater LLC
is
the investment manager of Rainbow Gate Corporation; (ii) warrants held by
Stillwater LLC to purchase 5,468,324
shares,
which includes: warrants to purchase 2,727,488
shares
held by Rainbow Gate Corporation, in which the sole member of Stillwater LLC
is
the investment manager of Rainbow Gate Corporation;
and
(iii) 2,692,307 shares of common stock underlying a 6% senior convertible note
held by Rainbow Gate Corporation, in which the sole member of Stillwater LLC
is
the investment manager of Rainbow Gate Corporation.
(2)
This
figure represents: (i) 7,390,235
shares
owned by Ginola Limited, which include 2,628,417
shares
held by Rainbow Gate Corporation, in
which
the sole shareholder of Ginola Limited is also the sole shareholder of Rainbow
Gate Corporation, 650,800
shares held
indirectly
by Ogier
Trustee(Jersey) Limited, as trustee, 573,707 shares held
indirectly
by
Chelsea Trust Company Limited, as trustee, and 396,223 shares held
indirectly
by
Crestflower Corporation. Ginola Limited disclaims beneficial ownership of the
shares owned by Crestflower Corporation, Ogier Trustee (Jersey) Limited, as
trustee, and Chelsea Trust Company Limited, as trustee; (ii) warrants held
by
Ginola Limited to purchase 5,943,403
common
shares, which includes warrants to purchase 2,727,488
shares
held by Rainbow Gate Corporation, in which the sole shareholder of Ginola
Limited is also the sole shareholder of Rainbow Gate Corporation, and warrants
to purchase 325,400 shares held
indirectly
by Ogier
Trustee (Jersey) Limited, as trustee and
272,727 shares of common stock issuable upon exercise of a common stock purchase
warrant held indirectly by Chelsea Trust Company Limited, as trustee.
Ginola
Limited disclaims beneficial ownership of the shares owned by Ogier Trustee
(Jersey) Limited, as trustee and
Chelsea Trust Company Limited, as trustee; and (iii) 5,769,230 shares of common
stock underlying a 6% senior convertible note, which includes 2,692,307 shares
of common stock underlying a 6% senior convertible note held by Rainbow Gate
Corporation, in which the sole shareholder of Ginola Limited is also the sole
shareholder of Rainbow Gate Corporation.
(4)
This
figure represents
2,628,417 shares of common stock, 2,727,488 shares of common stock issuable
upon
exercise of a common stock purchase warrant and 2,692,307 shares of common
stock
underlying a 6% senior convertible note.
(5)
This
figure includes 325,400 shares underlying warrants.
(6)
This
figure represents 191,984 shares owned by Mr. Cronson, 215,673, shares
underlying warrants. This includes (i) 120,974 common stock shares and 42,857
shares underlying warrants held indirectly by a family member of Paul Cronson;
and (ii) 43,651 shares underlying warrants held indirectly by Larkspur
Corporation of which he is the Managing Director. This does not include 104,000
shares underlying options which are not exercisable within 60 days of August
21,
2006.
(7)
This
figure represents shares underlying options. This does not include 182,000
shares underlying options which are not exercisable within 60 days of August
21,
2006.
(8)
This
figure represents shares owned by John Atherly. This does not include 854,500
shares underlying options which are not exercisable within 60 days of August
21,
2006.
(9)
This
does not include 120,250 shares underlying options which are not exercisable
within 60 days of August 21, 2006.
(10)
This
does not include 112,125 shares underlying options which are not exercisable
within 60 days of August 21, 2006.
(11)
This
does not include 100,750 shares underlying options which are not exercisable
within 60 days of August 21, 2006.
(12)
This
does not include 82,875 shares underlying options which are not exercisable
within 60 days of August 21, 2006.
(13)
This
does not include 39,000 shares underlying options which are not exercisable
within 60 days of August 21, 2006.
(14)
This
figure includes (i) 1,115,036 shares of common stock, and (ii) warrants to
purchase 343,181 shares of common stock. This figure does not include 326,600
shares of common stock beneficially owned by Mr. Auf der Hyde’s spouse. Mr. Auf
der Heyde disclaims beneficial ownership of the shares owned by his
spouse.
(15)
This
figure includes (i) warrants to purchase 558,854 shares of common stock, and
(ii) 878,916 shares of common stock issuable upon exercise of stock
options.
INFORMATION
ABOUT THE BOARD OF DIRECTORS
The
Board
of Directors oversees our business and affairs and monitors the performance
of
management. In accordance with corporate governance principles, the Board does
not involve itself in day-to-day operations. The directors keep themselves
informed through discussions with the Chief Executive Officer, other key
executives and by reading the reports and other materials that we send them
and
by participating in Board and committee meetings. Our directors hold office
until their successors have been elected and duly qualified unless the director
resigns or by reasons of death or other cause is unable to serve in the capacity
of director. Biographical information about our directors is provided in “Item 1
- Proposal for the Election of Class B Directors” on page 18.
During
2005, the Board of Directors held 8 meetings. Each director attended no fewer
than 75% of the aggregate of the total number of meetings of the Board and
the
total number of meetings held by all committees on which such director served.
The Board also approved certain actions by unanimous written consent.
What
committees has the Board established?
The
Board
of Directors has standing Audit, Compensation, Governance and Nominating. The
Board has also established a Management Committee comprised of both officers
and
directors. Information concerning the membership and function of each Board
committee is as follows:
BOARD
COMMITTEE MEMBERSHIP
Name
|
Audit
Committee
|
Compensation
Committee
|
Governance
and
Nominating Committee
|
Dr.
Radu Auf der Heyde
|
|
|
|
Claude
Charles
|
*
|
|
|
Paul
Cronson (1)
|
|
|
|
Irwin
Engelman
|
**
|
|
|
Jacob
Goldman
|
|
*
|
**
|
Gary
W. Jones
|
|
|
|
Rear
Admiral Thomas Paulsen, USN (Ret.) ***
|
*
|
**
|
*
|
Brig.
General Stephen Seay, U.S. Army (ret.)
|
|
|
|
Dr.
Jill Wittels
|
|
|
*
|
*
Member
of
Committee
** Chairman of
Committee
*** Chairman of the Board
Audit
Committee.
The
Audit Committee is responsible for determining the adequacy of the Company's
internal accounting and financial controls, reviewing the results of the audit
of the Company performed by the independent public accountants, and recommending
the selection of independent public accountants. The functions of the Audit
Committee and its activities during 2005 are described in more detail under
the
heading “ Report
of the Audit Committee.”
During
the year, the Board examined the composition of the Audit Committee in light
of
the adoption by The American Stock Exchange, Inc. (the “Amex”) of new rules
governing audit committees. Based upon this examination, Board has determined
that each of the members of the Audit Committee is unrelated, an outside member
with no other affiliation with the Company and is independent as defined by
the
American Stock Exchange. The Board has determined that Mr. Engelman is an “audit
committee financial expert” as defined by the SEC. During 2005, the Audit
Committee held five meetings.
Compensation
Committee.
The
Compensation Committee determines matters pertaining to the compensation and
expense reporting of certain executive officers of the Company, and administers
the Company's stock option, incentive compensation, and employee stock purchase
plans. During 2005, the Compensation Committee held three meetings.
Nomination
of Directors
As
provided in its charter and our company’s corporate governance principles, the
Governance and Nominating Committee is responsible for identifying individuals
qualified to become directors. The Governance and Nominating Committee seeks
to
identify director candidates based on input provided by a number of sources,
including (1) the Governance and Nominating Committee members, (2) our other
directors, (3) our stockholders, (4) our Chief Executive Officer or Chairman,
and (5) third parties such as professional search firms. In evaluating potential
candidates for director, the Nominating and Corporate Governance Committee
considers the entirety of each candidate’s credentials.
Qualifications
for consideration as a director nominee may vary according to the particular
areas of expertise being sought as a complement to the existing composition
of
the Board of Directors. However, at a minimum, candidates for director must
possess:
|
•
|
|
high
personal and professional ethics and
integrity
|
|
•
|
|
the
ability to exercise sound judgment
|
|
•
|
|
the
ability to make independent analytical
inquiries
|
|
•
|
|
a
willingness and ability to devote adequate time and resources to
diligently perform Board and committee
duties
|
|
•
|
|
the
appropriate and relevant business experience and
acumen
|
In
addition to these minimum qualifications, the Governance and Nominating
Committee also takes into account when considering whether to nominate a
potential director candidate the following factors:
|
•
|
|
whether
the person possesses specific industry expertise and familiarity
with
general issues affecting our
business
|
|
•
|
|
whether
the person’s nomination and election would enable the Board to have a
member that qualifies as an “audit committee financial expert” as such
term is defined by the Securities and Exchange Commission (the “SEC”) in
Item 401 of Regulation S-K
|
|
•
|
|
whether
the person would qualify as an “independent” director under the listing
standards of the American Stock
Exchange
|
|
•
|
|
the
importance of continuity of the existing composition of the Board
of
Directors to provide long term stability and experienced
oversight
|
|
•
|
|
the
importance of diversified Board membership, in terms of both the
individuals involved and their various experiences and areas of
expertise
|
The
Governance and Nominating Committee will consider director candidates
recommended by stockholders provided such recommendations are submitted in
accordance with the procedures set forth below. In order to provide for an
orderly and informed review and selection process for director candidates,
the
Board of Directors has determined that stockholders who wish to recommend
director candidates for consideration by the Governance and Nominating Committee
must comply with the following:
·
|
The
recommendation must be made in writing to the Corporate Secretary,
eMagin
Corporation, 10500 NE 8th
Street, Suite 1400, Bellevue, WA 98004. The recommendation must include
the candidate's name, home and business contact information, detailed
biographical data and qualifications, information regarding any
relationships between the candidate and the Company within the last
three
years and evidence of the recommending person's ownership of the
Company’s
common stock.
|
·
|
The
recommendation shall also contain a statement from the recommending
shareholder in support of the candidate; professional references,
particularly within the context of those relevant to board membership,
including issues of character, judgment, diversity, age, independence,
expertise, corporate experience, length of service, other commitments
and
the like; and personal references.
|
·
|
A
statement from the shareholder nominee indicating that such nominee
wants
to serve on the Board and could be considered "independent" under
the
Rules and Regulations of the American Stock Exchange and the Securities
and Exchange Commission ("SEC"), as in effect at that
time.
|
All
candidates submitted by stockholders will be evaluated by the Governance and
Nominating Committee according to the criteria discussed above and in the same
manner as all other director candidates.
Management Committee
On
August
15, 2006 the Board of Directors formed a management committee comprised of
officers and directors, which will be responsible for overseeing the Company’s
management, growth and related initiatives, and will report to the Board. The
Board appointed the following as members of the management committee: Gary
W.
Jones, Director and the Company’s Chief Executive Officer and President; John
Atherly, the Company’s Chief Financial Officer; and Dr. Radu Auf der Heyde,
Director.
How
are directors compensated?
Non-management
directors receive options under the 2003 Stock Option Plan (the "2003 Plan").
Under the 2003 Plan, a grant of options to purchase 60,000 shares of common
stock will automatically be granted on the date a director is first elected
or
otherwise validly appointed to the Board with an exercise price per share equal
to 100% of the market value of one share on the date of grant. Such options
granted will expire ten years after the date of grant and will become
exercisable in four equal installments commencing on the date of grant and
annually thereafter. In addition to the 60,000 shares of common stock
automatically granted upon joining the Board, Directors thereafter receive an
annual grant of options to purchase 10,000 shares of common stock at the fair
market value as determined on the date of grant, which options will vest on
December 31 in the year granted. In addition, each non-management director
is
reimbursed for ordinary expenses incurred in connection with attendance at
such
meetings, granted options based on committee assignments consisting of options
to purchase 5,000 shares per year for each committee assignment, except for
the
audit committee participants who each receive annual options to purchase 15,000
shares.
Effective
as of August 15, 2006, the Board of Directors appointed Dr. Radu Auf der Heyde
as a director of the Company, the first of two directors which the holders
of
our 6% Senior Secured Convertible Notes have the right to designate to the
Company’s Board. On August 15, 2006, the Board of Directors granted Dr. Auf der
Heyde options to purchase 60,000 shares of common stock. In addition, Dr. Auf
der Heyde was granted options to purchase 10,000 shares of common
stock.
Code
of Business Conduct and Ethics
We
have
adopted a Code of Business Conduct and Ethics that applies to all of our
directors, officers and employees, including our principal executive officer,
principal financial officer and principal accounting officer. The Code of
Business Conduct and Ethics can be found on our website at
http://www.emagin.com/investors.
We
intend
to satisfy the disclosure requirement under Item 10 of Form 8-K regarding an
amendment to, or waiver from, a provision of this Code of Business Conduct
and
Ethics by posting such information on our website, at the address and location
specified above and, to the extent required by the listing standards of the
American Stock Exchange, by filing a Current Report on Form 8-K with the SEC,
disclosing such information.
INFORMATION
ABOUT THE EXECUTIVE OFFICERS
The
executive officers are elected annually by our Board of Directors and hold
office until their successors are elected and duly qualified. The current
executive officers of the Company are as follows:
Name
|
Age
|
Position
|
Gary
Jones
|
51
|
President,
Chief Executive Officer, and Director
|
Susan
K. Jones
|
55
|
Chief
Strategy and Marketing Officer and Secretary
|
John
Atherly
|
47
|
Chief
Financial Officer
|
The
following includes the principal occupations for the past five years (and,
in
some instances, for prior years) of each of our executive officers (other than
those executive officers who are also directors):
John
Atherly
has
served as Chief Financial Officer since June 2004. Before joining eMagin
Corporation, Mr. Atherly worked for Click2learn, Inc., a NASDAQ listed
enterprise software company from 1990 to 2004. He held the positions of Vice
President of Finance and CFO for approximately 8 years and prior to that held
the positions of Director of Finance and Controller. During his 14 years with
Click2learn Mr. Atherly managed the firm's finance and administration, human
resources, IT and manufacturing organizations. From 1987 to 1990, Mr. Atherly
was a Finance and Operations Manager at MicroDisk Services, a manufacturing
firm
serving the software industry. Mr. Atherly holds a BA in Business Administration
from the University of Washington.
Susan
K. Jones
has
served as Executive Vice President and Secretary since 1992, and assumed
responsibility of Chief Marketing and Strategy Officer in 2001. Ms. Jones has
more than 25 years of industrial and management experience, including senior
research, marketing, and management assignments at Texas Instruments and Merck,
Sharp, and Dohme Pharmaceuticals. Ms. Jones serves on the boards or chairs
committees for industry organizations including IEEE, SPIE, and SID. Ms. Jones
served as a director of eMagin Corporation from 1993 to 2000 and was a director
of Virtual Vision, Inc. Ms. Jones graduated from Lamar University with a B.S.
in
chemistry and biology, holds more than a dozen patents, and has authored more
than 100 papers and talks.
The
Compensation Committee of the Board of Directors has furnished the following
report concerning the philosophy underlying the Company’s compensation of
executive officers.
The
Report of the Compensation Committee does not constitute soliciting material
and
should not be deemed filed or incorporated by reference into any other Company
filing under the Securities Act of 1933 or the Securities Exchange Act of 1934,
except to the extent the Company specifically incorporates this Report by
reference therein.
The
Company’s executive compensation program is designed to attract, retain and
motivate executive officers capable of leading the Company to meet its business
objectives, to align the interests of executive management with those of the
stockholders, and to provide incentives and reward both short and long term
performance based on the success of the Company in meeting its development
milestones and business objectives. The Compensation Committee places a
particular emphasis on variable, performance based components, such as the
bonus
potential and stock option awards, the value of which could increase or decrease
to reflect changes in corporate and individual performances.
Components
of Compensation.
Each
executive officer's compensation package is generally comprised of the following
elements: (1) A base salary which is established at levels considered
appropriate for the duties and scope of responsibilities of each officer's
position; (2) A performance-based annual bonus; (3) Periodic grants of stock
options to strengthen the mutuality of interests between the executive officers
and the Company's stockholders. Annual or quarterly cash bonuses related to
the
performance of the Company may be made to executive officers in the sales and
marketing functions, and other executive officers in certain other
circumstances, for such executive officer's functional area. Executive officers
are also eligible to participate in compensation and employee benefits generally
available to all employees of the Company, such as health insurance and
participation in the eMagin Employee Savings and Protection Plan ("401(k)
Plan").
The
Compensation Committee believes that this three-part approach best serves the
interests of the Company and its stockholders. It enables the Company to meet
the requirements of the highly competitive environment in which the Company
operates while ensuring that executive officers are compensated in a way that
advances both the short and long-term interests of stockholders. Under this
approach, compensation for these officers involves a high proportion of pay
that
is ‘‘at risk’’ - namely, the annual bonus and stock options. The variable annual
bonus is also based, in significant part, on Company performance. Stock options
relate a significant portion of long-term remuneration directly to stock price
appreciation realized by all of the Company’s stockholders.
Base
Salary.
Base
salaries for executive officers are set at levels believed by the Committee
to
be sufficient to attract and retain qualified executive officers based on the
stage of development of the Company, the salary levels in effect for comparable
positions in similarly situated companies within relevant industries, and
internal comparability considerations. Base salaries for the Company’s executive
officers other than the Chief Executive Officer, as well as changes in such
salaries, are based upon recommendations by the Chief Executive Officer, taking
into account such factors as competitive industry salaries, a subjective
assessment of the nature of the position and the contribution and experience
of
the officer and the length of the officer’s service. All such recommendations
are subject to approval or disapproval by the Compensation Committee. Other
than
provisions provided for in Employment Agreements, changes in base salaries
of
executives are based on an evaluation of the personal performance of the
executive, prevailing market practices, and the performance of the Company
as a
whole. In determining base salaries, the Compensation Committee not only
considers the short-term performance of the Company, but also the success of
the
executive officers in developing and executing the Company's strategic plans,
developing management employees and exercising leadership in the development
of
the Company.
Cash-Based
Incentive Bonus.
The
Compensation Committee believes that a portion of the total cash compensation
for executive officers should be based on the Company's success in meeting
its
short-term performance objectives and contributions by the executive officers
that enable the Company to meet its long-term objectives, and has structured
the
executive compensation program to reflect this philosophy. This approach creates
a direct incentive for executive officers to achieve desired short-term
corporate goals that also further the long-term objectives of the Company,
and
places a significant portion of each executive officer's annual compensation
at
risk.
Stock
Options.
The
Compensation Committee believes that equity participation is a key component
of
the Company's executive compensation program. Stock options are awarded by
the
Compensation Committee to executive officers primarily based on potential
contributions to the Company's growth and development and marketplace practices.
These awards are designed to retain executive officers and to motivate them
to
enhance stockholder value by aligning the financial interests of executive
officers with those of stockholders. Stock options provide an effective
incentive for management to create stockholder value over the long term because
the full benefits of the option grants cannot be realized unless an appreciation
in the price of the Company's common stock occurs over a number of
years.
Variable
Bonus.
The
Compensation Committee may award annual or interim Special Bonuses in the form
of cash, stock options, or restricted stock to executive management and
employees for achieving certain milestones, progress made in the staff and
organizational development of the Company, and advances in the market acceptance
and commercialization of the Company's technology.
Compensation
of Chief Executive Officer.
Mr.
Jones's base salary as of December 31, 2005, was $320,313 and was paid a
reimbursement for relocation expenses of $147,420. In addition, he was granted
options for 530,000 shares. In 2004, Mr. Jones invested a higher amount of
cash
into eMagin Corporation, by exercising options which had been granted in prior
years, than was paid to him during 2004 as salary. In 2006 Mr. Jones agreed
to
hold back 10% of his compensation and to waive increases in his compensation
until such time as the Company posts an EBITDA positive quarter or fulfills
other criteria as provided in the Company’s Note Purchase Agreement dated July
21, 2006.
Compensation
Committee
Thomas
Paulsen (Chairman)
Dr.
Jacob
Goldman
Compensation
Committee interlocks and insider participation
None
of
the members of the Compensation Committee is or has been an officer or employee
of the Company or any of its subsidiaries.
Summary
compensation table for named executive officers
The
following table provides information about the total compensation for services
in all capacities to the Company or its subsidiary for the last three fiscal
years of those persons who at December 31, 2005, were (i) the Chief Executive
Officer of the Company and (ii) the other most highly compensated executive
officers of the Company whose total annual salary and bonus exceeded $100,000
(collectively, the "named executive officers").
Name
and Positions
|
Year
|
Salary
|
Bonus
|
|
Other
Annual Compensation
|
Underlying
Options)
|
Gary
W. Jones
|
President,
Chief Executive
|
2005
|
320,313
|
0
|
(1)
|
147,4206
|
530,000
|
|
|
Officer,
and
|
2004
|
305,090
|
0
|
(1)
|
46,636
|
1,200,000
|
|
|
Director
|
2003
|
305,090
|
0
|
|
0
|
516,260
|
|
|
|
|
|
|
|
|
|
Susan
K. Jones
|
Chief
Strategy and
|
2005
|
259,568
|
$26,049
|
(2)
|
0
|
359,400
|
|
|
Marketing
Officer
|
2003
|
245,933
|
0
|
(2)
|
0
|
750,000
|
|
|
and
Secretary
|
2002
|
245,933
|
0
|
|
0
|
403,825
|
|
|
|
|
|
|
|
|
|
John
Atherly |
Chief
Financial Officer |
2005
|
221,406
|
0
|
(3)
|
0
|
430,000
|
|
|
|
2004
|
105,000
|
0
|
(3)
|
0
|
750,000
|
|
|
|
2003
|
N/A
|
0
|
|
0
|
N/A
|
(1)
In
2005, Mr. Jones was paid a base salary of $320,313. In addition, he received
$147,420 for reimbursement of relocation expenses. In addition, he was granted
options for 530,000 shares. In 2004, Mr. Jones was paid a base salary $305,090,
the balance of deferred pay in the amount of $140,798, as well as a
reimbursement for relocation expenses of $46,636. Mr. Jones was paid the balance
of his deferred pay through the application of these amounts to the exercise
of
options. Collectively, Gary Jones and Susan Jones paid eMagin approximately
$1.2
million in 2004 to exercise stock options. In May 2004, Mr. Jones was granted
1,200,000 shares as part of a company-wide bonus program.
(2)
In
2005, Ms. Jones was paid a base salary of $259,568. She also received a bonus
that was paid 45% in cash, $12,144 and 55% in a stock grant, $24,395. In 2004,
Ms. Jones was paid a base salary of $245,933 and the balance of deferred pay
in
the amount of $110,134. Ms. Jones was paid the balance of her deferred pay
through the application of these amounts to the exercise of options.
Collectively, Gary Jones and Susan Jones paid eMagin approximately $1.2 million
in 2004 to exercise stock options. In May 2004, Ms. Jones was granted 750,000
shares as part of a company-wide bonus program.
(3)
In
2005, Mr. Atherly was paid a base salary of $221,406. He was granted 430,000
shares. In 2004, Mr. Atherly's base salary was $210,000. He joined eMagin
Corporation in June 2004 and was paid a salary of $105,000 for the portion
of
the year he was employed by eMagin. He was granted 750,000 shares as part of
his
hiring package. Of these 750,000 option shares granted, 500,000 shares vest
quarterly over a period of five years. 250,000 shares are target incentive
options based on successful completion of four consecutive EBITA positive
quarters.
Options/SARs
Grants During Last Fiscal Year
The
following table provides information related to options granted to our named
executive officers during the fiscal year ended December 31, 2005.
Name
|
Number
of Securities Underlying Options Granted
|
%
of Total Options Granted in Fiscal 2005
|
Exercise
Price Per Share
|
Expiration
Date
|
Gary
W. Jones (1)
|
350,000
180,000
|
6%
3%
|
$1.02
$0.5
|
3/17/12
11/30/12
|
|
|
|
|
|
Susan
K Jones (1)
|
255,000
104,400
|
4%
3%
|
$1.02
$0.58
|
3/17/12
11/30/12
|
|
|
|
|
|
John
Atherly (1)
|
250,000
180,000
|
4%
3%
|
$1.02
$0.58
|
3/17/12
11/30/12
|
(1)
Options awarded as part of a company-wide bonus program.
Aggregated
Option Exercises in Last Fiscal Year and Fiscal Year-End Option
Value
The
following table provides information regarding the aggregate number of options
exercised during the fiscal year ended December 31, 2005, by each of the named
executive officers and the number of shares subject to both exercisable and
unexercisable stock options as of December 31, 2005. The common stock price
at
December 31, 2005 was $0.57 per share.
|
Shares
Acquired on Exercise
|
Value
Realized
|
#
of Securities Underlying Unexercised Options at
FY-End
Exercisable
|
Unexercisable
|
Value
of Unexercised In-the-money Options at FY-End
Exercisable
|
Unexercisable
|
Gary
Jones
|
----
|
----
|
2,093,937
|
1,096,667
|
$
177,199
|
----
|
Susan
K. Jones
|
----
|
----
|
1,968,208
|
784,167
|
$
94,092
|
----
|
John
Atherly
|
----
|
----
|
150,000
|
1,030,000
|
---
|
----
|
Compliance
with internal Revenue Code Section 162(m) disallows a tax deduction to publicly
held companies for compensation paid to certain of their executive officers
to
the extent that such compensation exceeds $1.0 million per covered officer
in
any fiscal year. The limitation applies only to compensation that is not
qualified performance based compensation under the IRS code.
Executive
Employment Agreements
On
January 24, 2006, pursuant to actions taken by the Compensation Committee of
our
Board of Directors, Mr. Gary W. Jones entered into a revised executive
employment agreement, to conform to the recently established Sarbanes-Oxley
requirements, in connection with his service as Chief Executive Officer and
President of the Company, and at the time also as Chairman of the Company.
Additionally, Ms. Susan K. Jones entered into a revised executive employment
agreement, to conform to the recently established Sarbanes-Oxley requirements,
in connection with her service as the Company’s Chief Marketing and Strategy
Officer, Executive Vice President and Corporate Secretary.
Each
agreement is effective for an initial term of three years, effective January
1,
2006. The agreements provides for an annual salary, benefits made available
by
the Company to its employees and eligibility for an incentive bonus pursuant
to
one or more incentive compensation plans established by the Company from time
to
time. The Company may terminate the employment of Mr. Jones and Mrs. Jones
at
any time with or without notice and with or without cause (as such term is
defined in the agreements). If the Mr. Jones’ and Mrs. Jones’ employment is
terminated without cause, or if Mr. Jones and Mrs. Jones resign with good reason
(as such term is defined in the agreements), or if Mr. Jones’ and Mrs. Jones’
respective positions are terminated or significantly changed as result of change
of control (as such term is defined in the agreements), Mr. Jones and Mrs.
Jones
shall be entitled to receive salary until the end of the agreement’s full term
or twelve months, whichever is greater, payment for accrued vacation, and
bonuses which would have been accrued during the term of the agreements. If
Mr.
Jones and Mrs. Jones voluntarily terminates employment with the Company, other
than for good reason or is terminated with cause (as such term is defined in
the
agreement), Mr. Jones and Mrs. Jones shall cease to accrue salary, vacation,
benefits, and other compensation on the date of the voluntary or with cause
termination. The Executive Employment Agreements include other conventional
terms and also contains invention assignment, non-competition, non-solicitation
and non-disclosure provisions.
On
April
17, 2006, the parties entered into amendments to the employment agreements
pursuant to which the parties clarified that the Company has agreed to pay
for
health benefits equivalent to medical and dental benefits provided during the
executive’s full time employment until the end of the agreement’s full term or
twenty-four (24) months, whichever is greater.
The
following Report of the Audit Committee does not constitute soliciting material
and should not be deemed filed or incorporated by reference into any other
Company filing under the Securities Act of 1933 or the Securities Exchange
Act
of 1934, except to the extent the Company specifically incorporates this Report
by reference therein.
Role
of the Audit Committee:
The
Audit
Committee’s primary responsibilities fall into three broad
categories:
First,
the
Committee is charged with monitoring the preparation of quarterly and annual
financial reports by the Company’s management, including discussions with
management and the Company’s outside auditors about draft annual financial
statements and key accounting and reporting matters;
Second,
the
Committee is responsible for matters concerning the relationship between the
Company and its outside auditors, including recommending their appointment
or
removal; reviewing the scope of their audit services and related fees, as well
as any other services being provided to the Company; and determining whether
the
outside auditors are independent (based in part on the annual letter provided
to
the Company pursuant to Independence
Standards Board Standard No.
1);
and
Third,
the
Committee oversees management’s implementation of effective accounting controls
and reviews recommendations of the Company’s internal auditing program. The
Committee also provides oversight and review of the Company’s senior executives’
expense reporting.
The
Committee has implemented procedures to ensure that during the course of each
fiscal year it devotes the attention that it deems necessary or appropriate
to
each of the matters assigned to it under the Committee’s charter. In overseeing
the preparation of the Company’s financial statements, the Committee met with
both management and the Company’s outside auditors, with and without management
present, to review and discuss all financial statements prior to their issuance
and to discuss significant accounting issues. Management advised the Committee
that all financial statements were prepared in accordance with generally
accepted accounting principles, and the Committee discussed the statements
with
both management and the outside auditors. The Committee’s review included
discussion with the outside auditors of matters required to be discussed
pursuant to Statement
on Auditing Standards No. 61 (Communication With Audit
Committees).
With
respect to the Company’s outside auditors, the Committee, among other things,
discussed with Eisner LLP matters relating to its independence, including the
disclosures made to the Committee as required by the Independence
Standards Board Standard No. 1 (Independence Discussions with Audit
Committees).
Audit
Fees and All Other Fees: For the years ended December 31, 2005 and 2004, the
aggregate fees payable to Eisner LLP for professional services rendered for
the
audit of the annual financial statements, review of quarterly financial
statements and services normally provided in connection with statutory and
regulatory filings or engagements were approximately $151,000 and $136,000,
respectively. There were no other fees billed for services rendered to the
Company by Eisner LLP, other than fees for audit and audit-related, for the
years 2005 and 2004. The Audit Committee has considered whether the provision
for services covered by fees other than audit fees is compatible with
maintaining the principal auditor’s independence.
Recommendations
of the Audit Committee
In
reliance on the reviews and discussions referred to above, the Audit Committee
recommended to the Board of Directors that the Board approve the inclusion
of
the Company’s audited financial statements in the Company’s Annual Report on
Form 10-K for the fiscal year ended December 31, 2005, for filing with the
Securities and Exchange Commission. The Audit Committee has also recommended
to
the Board of Directors, subject to stockholder ratification, the selection
of
Eisner LLP as the Company’s independent auditors for 2006, and the Board
concurred in its recommendation.
Audit
Committee:
Irwin
Engelman (Chairman)
Claude
Charles
Thomas
Paulsen
On
October 20, 2005, we entered into a Securities Purchase Agreement to sell to
certain qualified institutional buyers and accredited investors an aggregate
of
16,619,056 shares of our common stock, par value $0.001 per share, and warrants
to purchase an additional 9,971,427 shares of common stock, for an aggregate
purchase price of approximately $9.14 million. The purchase price of the common
stock and corresponding warrant was $0.55 per share.
The
warrants are exercisable at a price of $1.00 per share and expire on October
20,
2010. Of the 9,971,427 warrants, 6,647,623 of the warrants are exercisable
on or
after May 20, 2006. The remaining 3,323,810 are exercisable after March 31,
2007, however these warrants will be cancelled if the Company’s net revenue for
fiscal year 2006 exceeds $20 million or if the investor has sold more than
25%
of the shares purchased under the Securities Purchase Agreement prior to
December 31, 2006.
Both
Stillwater LLC
and
Ginola Limited are beneficial owners of more than 5% of the Company’s common
stock.
Rainbow
Gate Corporation, a corporation in which its investment manager is the sole
member of Stillwater LLC and its controlling shareholder is the same as Ginola
Limited, participated in the sale of equity pursuant to the Securities Purchase
Agreement by investing approximately $500 thousand. Stillwater LLC disclaims
beneficial ownership of shares owned by Rainbow Gate Corporation.
Chelsea
Trust Company Limited, as trustee of a trust with the same directors and/or
controlling shareholders as Ginola Limited, participated in the sale of equity
pursuant to the Securities Purchase Agreement by investing approximately $250
thousand. Ginola Limited disclaims beneficial ownership of shares owned by
Chelsea Trust Company Limited.
In
connection with the issuance of the Shares and the warrants pursuant to the
Securities Purchase Agreement, the Company was required to lower the exercise
prices of existing Series A and F warrants from $1.05 and $1.21, respectively,
to $.55 and $1.09 per share, respectively, pursuant to the anti-dilution
provisions of the Series A and F warrants.
Mary
Cronson, the mother of an outside director of eMagin, Paul Cronson, is the
holder of a Series A warrant to purchase an aggregate of 42,857 shares of common
stock. Accordingly, the exercise price of Mrs. Cronson’s Series A warrant was
reduced from $1.05 to $0.55 per share. Mrs. Cronson received the same
considerations as all other holders of the Company’s Series A warrants which
were re-priced.
On
January 24, 2006, pursuant to actions taken by the Compensation Committee of
our
Board of Directors, Mr. Gary W. Jones entered into a revised executive
employment agreement, to conform to the recently established Sarbanes-Oxley
requirements, in connection with his service as Chief Executive Officer and
President of the Company. Mr. Jones also serves as Chairman of the Company.
Additionally, Ms. Susan K. Jones entered into a revised executive employment
agreement, to conform to the recently established Sarbanes-Oxley requirements,
in connection with her service as the Company’s Chief Marketing and Strategy
Officer, Executive Vice President and Corporate Secretary.
Each
agreement is effective for an initial term of three years, effective January
1,
2006. The agreements provides for an annual salary, benefits made available
by
the Company to its employees and eligibility for an incentive bonus pursuant
to
one or more incentive compensation plans established by the Company from time
to
time. The Company may terminate the employment of Mr. Jones and Mrs. Jones
at
any time with or without notice and with or without cause (as such term is
defined in the agreements). If the Mr. Jones’ and Mrs. Jones’ employment is
terminated without cause, or if Mr. Jones and Mrs. Jones resign with good reason
(as such term is defined in the agreements), or if Mr. Jones’ and Mrs. Jones’
respective positions are terminated or significantly changed as result of change
of control (as such term is defined in the agreements), Mr. Jones and Mrs.
Jones
shall be entitled to receive salary until the end of the agreement’s full term
or twelve months, whichever is greater, payment for accrued vacation, and
bonuses which would have been accrued during the term of the agreements. If
Mr.
Jones and Mrs. Jones voluntarily terminates employment with the Company, other
than for good reason or is terminated with cause (as such term is defined in
the
agreement), Mr. Jones and Mrs. Jones shall cease to accrue salary, vacation,
benefits, and other compensation on the date of the voluntary or with cause
termination. The Executive Employment Agreements include other conventional
terms and also contains invention assignment, non-competition, non-solicitation
and non-disclosure provisions.
On
July
21, 2006, we entered into several Note Purchase Agreements (the “Purchase
Agreements”) to sell to certain qualified institutional buyers and accredited
investors up to $5,970,000 in principal amount 6% Senior Secured Convertible
Notes Due 2007-2008, together with warrants to purchase 16,073,067 shares of
our
common stock, par value $0.001 per share.
Fifty
percent of the aggregate principle amount of each note matures 1 year
after the date of issuance and the remaining 50% matures 18 months after the
date of issuance. The Notes pay 6% interest quarterly, commencing on September
1, 2006, and are convertible into shares of common stock at a conversion price
equal to $0.26 per share. The warrants are exercisable into shares of our common
stock until July 21, 2011 at an exercise price of $0.36 per share.
Paul
Cronson, a Director, John Atherly, Chief Financial Officer, and Olivier Prache,
Senior Vice President of Display Manufacturing and Development Operations of
our
company participated in the private placement through the purchase of an
aggregate of $270,000 in principal amount of notes, together with warrants
to
purchase an aggregate of 726,921 shares of common stock, each on the same terms
and conditions as the other investors under the Purchase
Agreements.
In
addition to the foregoing, on July 21, 2006, we entered into an additional
Note
Purchase Agreement with Stillwater LLC which provides for the purchase and
sale
of an additional Note in the principal amount of up to $500,000 (the “Stillwater
Note”), together with a warrant (the “Stillwater Warrant”) to purchase 70% of
the number of shares issuable upon conversion of the Stillwater Note, at our
sole discretion by delivery of a notice to Stillwater LLC on December 14, 2006
for the completion of the purchase and sale to occur on December 29, 2006.
Our
ability to require Stillwater LLC to purchase and pay for the Stillwater Note
and Stillwater Warrant shall be reduced by the sum of (i) the additional
financing raised by us prior to the Closing Date, and (ii) the aggregate
exercise price paid by Stillwater LLC to us upon exercise of all or a portion
of
any of our common stock purchase warrants owned by Stillwater LLC prior to
the
Closing Date, including a warrant to purchase 1,923,077 shares of our
common stock which we issued to Stillwater LLC on July 21, 2006 (the “July
Warrant”), on similar terms and conditions as the Warrants set forth above,
with an exercise price of $0.26.
The
conversion price of the Stillwater Note shall be equal to 100% of the market
price of the common stock on December 13, 2006 and the exercise price of the
Stillwater Warrant will be equal to 100% of the market price of the common
stock
on December 13, 2006, plus $0.10.
Both
Stillwater LLC
and
Ginola Limited are beneficial owners of more than 5% of the Company’s common
stock.
Rainbow
Gate Corporation, a corporation in which its investment manager is the sole
member of Stillwater LLC and its controlling shareholder is the same as Ginola
Limited, participated in the sale of debt pursuant to the Purchase Agreement
by
investing approximately $700,000. Stillwater LLC disclaims beneficial ownership
of shares owned by Rainbow Gate Corporation. In addition, Ginola Limited
participated in the sale of debt pursuant to the Purchase Agreement by investing
approximately $800,000.
ACTIONS
TO BE TAKEN AT THE MEETING
ELECTION
OF CLASS B DIRECTORS
At
the
2001 Annual Meeting of Stockholders held on July 16, 2001, the stockholders
approved the establishment of a classified board of directors, divided into
three classes having staggered terms of three years each. Under the classified
board provision, the board of directors was divided into three classes,
designated Class A, Class B and Class C. At that time it was established that
each director in Class A would hold office until the 2005 annual meeting of
stockholders; any director in Class B would hold office until the 2006 annual
meeting of stockholders; and any director in Class C will hold office until
the
2007 annual meeting of stockholders; and, in each case, until their successors
are duly elected and qualified or until their earlier resignation, removal
from
office or death. As a result, only one class of directors will be elected at
each annual meeting of stockholders, with the remaining classes continuing
their
respective three-year terms. In 2005 the nominated Class A directors were
elected for a three-year term to hold office until the 2008 Annual Meeting
of
Stockholders.
At
this
year’s Annual Meeting, the stockholders will elect three Class B directors to
serve until the 2009 Annual Meeting of Stockholders or until their successors
are elected and qualified. In the event the nominees are unable or unwilling
to
serve as directors at the time of the Annual Meeting, the proxies will be voted
for any substitute nominees designated by the present Board or the proxy holders
to fill such vacancy, or for the balance of the nominees named without
nomination of a substitute, or the size of the Board will be reduced in
accordance with the Bylaws of the Company. The Board has no reason to believe
that the persons named below will be unable or unwilling to serve as nominees
or
as directors if elected.
Assuming
a
quorum is present, the three nominees receiving the highest number of
affirmative votes of shares entitled to be voted for such persons will be
elected as directors of the Company for the ensuing three years. Unless marked
otherwise, proxies received will be voted “FOR” the election of the nominees
named below. In the event that additional persons are nominated for election
as
directors, the proxy holders intend to vote all proxies received by them in
such
a manner as will ensure the election of the nominees listed below, and, in
such
event, the specific nominees to be voted for will be determined by the proxy
holders.
Information
With Respect to Director Nominees
Listed
below
are the nominees for Class B directors, with information showing the principal
occupation or employment of the nominees for director, the principal business
of
the corporation or other organization in which such occupation or employment
is
carried on, and such nominees’ business experience during the past five years.
Such information has been furnished to the Company by the director
nominees:
Class B Nominees
Name
|
Age
|
Class
|
Position
|
Paul
C. Cronson
|
48
|
B
|
Director
|
Rear
Admiral Thomas Paulsen, USN (Ret.)
|
70
|
B
|
Director
|
Brigadier
Gen. Stephen Seay, US Army (Ret.)
|
60
|
B
|
Director
|
Paul
C. Cronson
|
Director
Since 2003
|
Paul
Cronson has served as a director since July of 2003. Mr. Cronson is Managing
Director of Larkspur Capital Corporation, which he founded in 1992. Larkspur
is
a broker dealer that is a member of the National Association of Securities
Dealers and advises companies seeking private equity or debt. Mr. Cronson's
career in finance began in 1979 at Laidlaw, Adams Peck where he worked in asset
management and corporate finance. From 1983 to 1985, Mr. Cronson worked with
Samuel Montagu Co., Inc. in London, where he marketed eurobond issuers and
structured transactions. Subsequently from 1985 to 1987, he was employed by
Chase Investment Bank Ltd., where he structured international debt securities
and he developed "synthetic asset" products using derivatives. Returning to
the
U.S., he joined Peter Sharp Co., where he managed a real estate portfolio,
structured financings and assisted with capital market investments from until
1992. Mr. Cronson received his BA from Columbia College in 1979, and his MBA
from Columbia University School of Business Administration in 1982.
Rear
Admiral Thomas Paulsen, USN (Ret.)
|
Director
Since 2003
|
Admiral
Thomas Paulsen has served as a director since July 2003 and was elected as
Non-Executive Chairman in July 2006. Admiral Thomas Paulsen served for over
34
years in the US Navy in Command Control, Communications and Intelligence (C3I),
Telecommunications, Network Systems Operations, Computers and Computer Systems
Operations until his retirement in 1994 as a Rear Admiral. He then served as
Chief Information Officer for Williams Telecommunications. Admiral Paulsen
has
served as a director Umbanet, Inc. since 2002. Since 2000, Admiral Paulsen
has
served on the Board of Governors of the Institute of Knowledge Management,
George Washington University. Since 1994, he has served as the Chairman of
the
Advisory Board and President Emeritus of the Center for Advanced Technologies
(CAT) and a Managing Partner on the National Knowledge and Intellectual Property
Management Taskforce, a not-for-profit company headquartered in Dallas, Texas,
and is a member of the Board of Governors for the Japanese American National
Museum, Los Angeles, California.
Brigadier
General Stephen M. Seay, US Army (Ret.)
|
Director
Since 2005
|
General
Stephen M. Seay jointed the Board of Directors for eMagin Corporation since
leaving active military service in September 2005. Additionally,
he is a Director for Atlantis Cyberspace, Inc. (Hawaii-Simulation and
Training) and is proud to be a member of the Board of Directors for
Kid's House of Seminole County, Florida (Child Advocacy), also since
leaving military service. On active duty, he held a wide variety of
command and staff positions during his 33-year Army career, most
importantly volunteering for assignment with his troops in Iraq during
2004-2005. Most recently, he was Program Executive Officer for Simulation,
Training and Instrumentation, and Commanding General, Joint Contracting
Command-Iraq/Head of Contracting Authority, Operation Iraqi Freedom.
He served as Program Manager for a joint system, headed the Joint Target
Oversight Council and was Commanding General, Simulation, Training and
Instrumentation Command (STRICOM), Army Materiel Command. Earlier, as a Field
Artillery officer, he commanded at all levels, rising to corps artillery
commander. He served as Chief of Staff, United States Army, Europe
(Forward) and National Security Element, Taszar, Hungary, Operation Joint
Endeavor. He held resource management, operations research, and
acquisition positions during three tours on Department of the Army staff.
He holds a Bachelor of Science degree from the University of New Hampshire
and a Master of Science degree from North Carolina State
University.
Information
With Respect to Continuing Directors
Listed
below are the continuing Class A and C directors, with information showing
the
principal occupation or employment of the director, the principal business
of
the corporation or other organization in which such occupation or employment
is
carried on, and such director’s business experience during the past five years.
Such information has been furnished to the Company by the
directors:
Name
|
Age
|
Class
|
Position
|
Irwin
Engelman
|
71
|
A
|
Director
|
Gary
W. Jones
|
51
|
A
|
Director
|
Dr.
Radu Auf der Heyde
|
37
|
C
|
Director
|
Claude
Charles
|
69
|
C
|
Director
|
Dr.
Jacob (Jack) Goldman
|
83
|
C
|
Director
|
Dr.
Jill Wittels
|
57
|
C
|
Director
|
Irwin
Engelman
|
Director
Since 2005
|
Irwin
Engelman has been a director of eMagin since 2005. Mr. Engelman has been a
director of New Plan Excel Realty Trust, Inc., a publicly-traded company that
is
one of the nation's largest owners and managers of community and neighborhood
shopping centers, since 2003. He is currently a consultant to various industrial
companies.
From
November 1999 until April 2002, he served as Executive Vice President
and Chief Financial Officer of YouthStream Media Networks, Inc., a media
and retailing company serving high school and college markets. From 1992 until
April 1999, he served as Executive Vice President and Chief Financial
Officer of MacAndrews and Forbes Holdings, Inc., a privately-held
financial holding company. From November 1998 until April 1999, he
also served as Vice Chairman, Chief Administrative Officer and a director of
Revlon, Inc., a publicly-traded consumer products company. From 1978 until
1992, he served as an executive officer of various public companies including
International Specialty Products, Inc. (a subsidiary of GAF Holdings Inc.),
CitiTrust Bancorporation, General Foods Corporation and The Singer Company.
He
is currently a director of Sanford Bernstein Mutual Funds, a publicly-traded
company, and a member of its audit committee. Mr. Engelman received a BBA in
Accounting from Baruch College in 1955 and a Juris Doctorate from Brooklyn
Law
School in 1961. He was admitted practice law in the State of New York in 1962.
In addition, he was licensed as a CPA in the State of New York in
1966.
Gary
W. Jones
|
Director
since 1992
|
Gary
W.
Jones has served as Chief Executive Officer, and President of eMagin since
1992,
as Acting Chief Financial Officer from August 2002 to June 2004, and as Chairman
from 1992 to 2006. Mr. Jones has over 20 years of experience in both public
and
private companies in the areas of business development, high volume
manufacturing, product development, research, and marketing. Prior to founding
FED Corporation/eMagin Corporation, Mr. Jones served as Director of the Device
Development and Processing division at MCNC Center for Microelectronics in
North
Carolina from 1985 to 1992. From 1977 to 1985 Mr. Jones managed both
semiconductor manufacturing and research and development programs at Texas
Instruments. Mr. Jones received a B.S. in electrical engineering and physics
from Purdue University. Mr. Jones has served as a member of the Executive
Committee of the Board of the United States Display Consortium.
Dr.
Radu Auf der Heyde
|
Director
since 2006
|
From
October 2005 to the present, Dr. Auf der Heyde has served as President of
Lightridge Capital, an investment management firm he founded which uses
artificial intelligence technology to assist in decision-making to yield high
risk-adjusted returns on investment. From June 2003 to September 2005, he served
as Vice President of Ameriquest Capital, a private equity firm. Aside from
investing activities, he led various efforts at Ameriquest Capital’s portfolio
companies, including setting up a program management and a software development
quality assurance group, replacing core business applications, upgrading IT
and
communication infrastructures, and restructuring a call center. From September
1999 to June 2003, Dr. Auf der Heyde worked as a Principal at Mercer Management
Consulting with a primary focus on business strategy development and new venture
creation for a variety of leading electronic equipment manufacturers, technology
services companies and telecommunication service providers. Dr. Auf der Heyde
received a Ph.D. in engineering from Stanford University in 1999 and holds
a
diploma degree in engineering from the Technical University of Aachen (RWTH
Aachen), Germany, which he received in 1993.
Claude
Charles
|
Director
since 2000
|
Claude
Charles has served as a director since April of 2000. Mr. Charles has served
as
President of Great Tangley Corporation since 1999. From 1996 to 1998 Mr. Charles
was Chairman of Equinox Group Holdings. Mr. Charles has also served as a
director and in senior executive positions at SG Warburg and Co. Ltd., Peregrine
Investment Holdings, Trident International Finance Ltd., and Dow Banking
Corporation. Mr. Charles holds a B.S. in economics from the Wharton School
at
the University of Pennsylvania and a M.S. in international finance from Columbia
University.
Dr.
Jack Goldman
|
Director
since 2003
|
Dr.
Jack Goldman joined our board of directors in February of 2003. Dr. Goldman
is
the retired senior vice-president for R&D and chief technical officer of the
Xerox Corporation. While at Xerox, he founded and directed the celebrated Xerox
PARC laboratory. Prior to joining Xerox, Dr. Goldman was Director of Ford Motor
Company's Scientific Research Laboratory. He also served as Visiting Edwin
Webster Professor at MIT. Dr. Goldman presently serves on the Boards of
Directors of Umbanet Inc. and Medis Technologies Inc., and he has served on
the
Boards of Xerox, General Instrument Corp., United Brands, Intermagnetics
General, GAF and Bank Leumi USA. He has also been active in government and
professional advisory roles including service on the US Dept. of Commerce
Technical Advisory Board, chairman of Statutory Visiting Committee of The
National Bureau of Standards (National Institute of Standards and Technology),
vice-president of the American Association for the Advancement of Science and
president of the Connecticut Academy of Science and Engineering.
Dr.
Jill Wittels
|
Director
since 2003
|
Dr.
Jill
Wittels has served as a director since July 2003. Since February 2001, Dr.
Wittels has been the Corporate Vice President, Business Development for L-3
Communications, a merchant supplier of intelligence, surveillance and
reconnaissance systems and products, secure communications systems and products,
avionics and ocean products, training devices and services, microwave components
and telemetry, instrumentations, space and navigation products. Dr. Wittels
has
over 25 years of management, engineering and leadership experience. Prior to
L-3
Communications, Dr. Wittels worked for 21 years with BAE Systems and its
predecessor companies, including Lockheed Martin, Loral and Honeywell. Most
recently, she served as vice president and general manager of BAE Systems'
Information and Electronic Warfare Systems/Infrared and Imaging Systems
division. Dr. Wittels began her career as a systems engineer and has also served
as a Congressional Fellow for the American Physical Society, a research
associate at Massachusetts Institute of Technology and a senior visiting
scientist for the National Academy of Sciences. Dr. Wittels received a Bachelor
of Science degree in Physics from MIT in 1970 and received a PhD in Physics from
MIT in 1975. She serves on the Board of Overseers for the Department of Energy's
Fermi National Accelerator Lab, is a member of the American Physical Society
and
a member of the American Astronomical Society. Dr. Wittels presently serves
on
the Boards of Directors of Innovative Micro Technology Inc. and of Millivision
Inc.
Required
Vote
The
election of the directors of the Company requires the affirmative vote of a
plurality of the votes cast by stockholders present in person or represented
by
proxy at the Annual Meeting, which will be the nominees receiving the largest
number of votes, which may or may not constitute less than a
majority.
RECOMMENDATION
OF THE BOARD FOR PROPOSAL NO. 1:
THE
BOARD RECOMMENDS A VOTE FOR THE ELECTION OF ALL THE ABOVE
NOMINEES.
PROPOSAL
TO AMEND THE COMPANY’S CERTIFICATE OF INCORPORATION TO
INCREASE THE MAXIMUM NUMBER OF DIRECTORS WHICH MAY BE APPOINTED TO THE COMPANY’S
BOARD OF DIRECTORS FROM 9 TO 10 PERSONS
As
discussed in this proxy statement, the Company entered into several Note
Purchase Agreements (the “Purchase Agreements”) on July 21, 2006 to sell to
certain qualified institutional buyers and accredited investors up to $5,970,000
in principal amount 6% Senior Secured Convertible Notes Due 2007-2008, together
with warrants to purchase 16,073,067 shares of the Company’s common stock. Under
the Purchase Agreements, the investors have the right to designate two persons
to serve on the Company’s Board of Directors.
Effective
as of August 15, 2006, the Board of Directors appointed Dr. Radu Auf der Heyde
as a director of the Company, the first of two directors which the investors
have the right to designate to the Company’s Board. With the election of Dr. Auf
der Heyde, the Company’s Board of Directors now consists of 9
members.
Article
Six(a) of the Company’s Amended and Restated Certificate of Incorporation
provides that the Board of Directors of the Company shall consist of between
3
and 9 members as may be fixed from time to time by the Board of
Directors pursuant to a resolution adopted by a majority of the Board of
Directors . Effective August 15, 2006, our Board of Directors approved an
amendment to Article Six(a) of the Company’s Amended and Restated Certificate of
Incorporation to increase the maximum number of directors which may be appointed
to the Board from 9 to 10 persons in order to create an additional space on
the
Board of Directors to allow for the nomination of a second director by the
investors to the Company’s Board, which shall be subject to approval by the
Board of Directors.
Required
Vote
Approving
of the amendment to the Company's Certificate of Incorporation to increase
the
maximum number of directors which may be appointed to the Company’s Board of
Directors from 9 to 10 persons requires the affirmative vote of the holders
of
at least 66 2/3% of the shares of common stock present in person or represented
by proxy and entitled to vote at the Annual Meeting. As of the record date,
an
aggregate of 101,316,118 shares of our common stock was issued and outstanding.
Accordingly, the affirmative vote of approximately 67,537,324 shares of common
stock is required for approval of this Proposal 2.
RECOMMENDATION
OF THE BOARD FOR PROPOSAL NO. 2:
THE
BOARD RECOMMENDS A VOTE FOR THE APPROVAL OF THE
AMENDMENT
TO THE COMPANY’S CERTIFICATE OF INCORPORATION TO
INCREASE
THE MAXIMUM NUMBER OF DIRECTORS WHICH MAY BE APPOINTED
TO
THE COMPANY’S BOARD OF DIRECTORS FROM 9 TO 10 PERSONS
ITEM
3
APPROVAL
OF THE REVERSE STOCK SPLIT
The
Board
of Directors has unanimously adopted a resolution approving, declaring advisable
and recommending to the stockholders for their approval an amendment to our
amended and restated certificate of incorporation to effect a reverse stock
split of outstanding shares of common stock at a ratio of
one-for-ten.
The
reverse stock split will be affected by filing an amendment to our amended
and
restated certificate of incorporation with the State of Delaware. The
certificate of amendment will effect a reverse stock split of the shares by
reducing the number of issued and outstanding shares of common stock by the
ratio determined by the board of directors to be in the best interests of the
Company and its stockholders, but will not change the number of authorized
shares of common stock or preferred stock or the par value of the common stock
or preferred stock. A copy of the proposed amendment to our certificate of
incorporation effecting the 1-for-10 reverse stock split is attached at the
back
of this proxy statement as Appendix A.
Reasons
for Board Recommendation
The
Board
of Directors is recommending that you empower the Board of Directors to
effectuate, in the Board of Directors’ discretion, the reverse stock split
within the foregoing ratios for the following reasons:
·
|
Because
the Board of Directors believes a higher stock price may help generate
investor interest in the Company and help the Company attract and
retain
employees and other service providers;
|
·
|
Because
the Company agreed to use its best efforts to effectuate the proposed
split, subject to stockholder approval, pursuant to certain Note
Purchase
Agreements dated July 21, 2006, for the purchase and sale of convertible
notes and warrants to certain accredited and/or institutional investors
(as further described below); and
|
·
|
Because
the Company requires additional authorized but unissued shares of
common
stock.
|
The
Board
of Directors believes that a higher stock price would help the Company attract
and retain employees and other service providers. The Board of Directors
believes that some potential employees and service providers are less likely
to
work for a company with a low stock price, regardless of the size of the
company’s market capitalization. If the reverse stock split successfully
increases the per share price of our common stock, the Board of Directors
believes this increase will enhance our ability to attract and retain employees
and service providers. Further, in deciding at what ratio to effectuate the
reverse stock split, the Board of Directors will consider that our common stock
may not appeal to brokerage firms that are reluctant to recommend lower priced
securities to their clients. Investors may also be dissuaded from purchasing
lower priced stocks because the brokerage commissions, as a percentage of the
total transaction, tend to be higher for such stocks. Moreover, the analysts
at
many brokerage firms do not monitor the trading activity or otherwise provide
coverage of lower priced stocks. Most investment funds are reluctant to invest
in lower priced stocks.
The
increase in the number of authorized but unissued shares of common stock would
enable the Company, without further stockholder approval, to issue shares from
time to time as may be required for proper business purposes, such as raising
additional capital for ongoing operations, business and asset acquisitions,
stock splits and dividends, present and future employee benefit programs and
other corporate purposes. In addition, the Board of Directors believes that
having additional authorized but unissued shares of common stock through the
effectuation of the reverse stock split could have a number of effects on the
Company's stockholders depending upon the exact nature and circumstances of
any
actual issuances of authorized but unissued shares. The increase could have
an
anti-takeover effect, in that additional shares could be issued (within the
limits imposed by applicable law) in one or more transactions that could make
a
change in control or takeover of the Company more difficult. For example,
additional shares could be issued by the Company so as to dilute the stock
ownership or voting rights of persons seeking to obtain control of the Company.
Similarly, the issuance of additional shares to certain persons allied with
the
Company's management could have the effect of making it more difficult to remove
the Company's current management by diluting the stock ownership or voting
rights of persons seeking to cause such removal. Except as further discussed
herein, the Board of Directors is not aware of any attempt, or contemplated
attempt, to acquire control of the Company, and this proposal is not being
presented with the intent that it be utilized as a type of anti-takeover
device.
Except
for the following, there are currently no plans, arrangements, commitments
or
understandings for the issuance of the additional shares of common stock which
are proposed to be authorized:
July
2006 Note Purchase Agreements
On
July
21, 2006, we entered into several Note Purchase Agreements (the “Purchase
Agreements”) to sell to certain qualified institutional buyers and accredited
investors up to $5,970,000 in principal amount 6% Senior Secured Convertible
Notes Due 2007-2008, together with warrants to purchase 16,073,067 shares of
our
common stock, par value $0.001 per share. In addition, $20,000 of fees due
to
our investment banker was paid through participation in the notes transaction
and convertible into 76,923 common shares with warrants to purchase 53,846
shares of our common stock.
50%
of
the aggregate principle amount of each Note matures 1 year after the
date of issuance and the remaining 50% matures 18 months after the date of
issuance. The Notes pay 6% interest quarterly, commencing on September 1, 2006,
and are convertible into shares of common stock at a conversion price equal
to
$0.26 per share (the “Conversion Price”). In addition, we have the right to
redeem all of the outstanding principal and accrued and unpaid interest due
under the Notes upon certain conditions, including, but not limited to, that
no
event of default has occurred or is continuing and that there is an effective
registration statement registering the shares underlying the Notes and the
Warrants.
The
Warrants are exercisable into shares of our common stock until July 21, 2011
at
an exercise price of $0.36 per share (the “Exercise Price”). The investors may
exercise the Warrants on a cashless basis beginning one year after the date
of
issuance if the shares of common stock underlying the Warrants are not then
registered pursuant to an effective registration statement or if an event of
default, as defined in the Notes, has occurred and is continuing.
The
Conversion Price and the Exercise Price are subject to adjustment for certain
events, including the payment of dividends, distributions or split of our common
stock, or in the event of our consolidation, merger or reorganization. In
addition, the Conversion Price and the Exercise Price are also subject to
adjustment in the event that our Chief Executive Officer, Chief Financial
Officer or Chief Strategy Officer sells, transfers or disposes of shares of
common stock or securities convertible into our common stock, other than 50,000
shares of common stock in any fiscal quarter which our Chief Financial Officer
is permitted to sell on or after January 1, 2007. In such event the Conversion
and Exercise Prices shall be reduced, if applicable, to a price equal to the
average of the daily volume weighted average prices for each of the three
trading days following the date such sale, transfer or disposition is reported,
or required to be reported, on a Form 4 filing with the Securities and Exchange
Commission (the “Commission”); provided,
that,
if such
an adjustment would require us to seek stockholder approval of the transactions
in accordance with Rule 713 of the American Stock Exchange Company Guide,
then such adjustment shall not reduce the Conversion Price or Exercise
Price to a price lower than the Conversion Price until such time as stockholder
approval is obtained.
Paul
Cronson, a Director, John Atherly, Chief Financial Officer, and Olivier Prache,
Senior Vice President of Display Manufacturing and Development Operations of
our
company participated in the private placement through the purchase of an
aggregate of $270,000 in principal amount of Notes, together with Warrants
to
purchase an aggregate of 726,921 shares of common stock, each on the same terms
and conditions as the other investors.
In
addition to the foregoing, on the same date, we entered into an additional
Note
Purchase Agreement with Stillwater LLC which provides for the purchase and
sale
of an additional Note in the principal amount of up to $500,000 (the “Stillwater
Note”), together with a warrant (the “Stillwater Warrant”) to purchase 70% of
the number of shares issuable upon conversion of the Stillwater Note, at our
sole discretion by delivery of a notice to Stillwater LLC on December 14, 2006
for the completion of the purchase and sale to occur on December 29, 2006
(the "Closing Date"). Our ability to require Stillwater LLC to purchase and
pay for the Stillwater Note and Stillwater Warrant shall be reduced by the
sum
of (i) the additional financing raised by us prior to the Closing Date, and
(ii)
the aggregate exercise price paid by Stillwater LLC to us upon exercise of
all
or a portion of any of our common stock purchase warrants owned by Stillwater
LLC prior to the Closing Date, including a warrant to purchase
1,923,077 shares of our common stock which we issued to Stillwater LLC on
July 21, 2006 (the “July Warrant”) on similar terms and conditions as the
Warrants set forth above, with an exercise price of $0.26. We are
registering the shares of common stock underlying the July Warrant in this
prospectus. The conversion price of the Stillwater Note shall be equal to 100%
of the market price of the common stock on December 13, 2006 and the exercise
price of the Stillwater Warrant will be equal to 100% of the market price of
the
common stock on December 13, 2006, plus $0.10. Further, we are obligated to
use
our best efforts to register the shares underlying the Stillwater Note,
and the Stillwater Warrant no later than 90 days after the Closing
Date. In the event of a default of our registration obligations, including
our
agreement to file the registration statement with the Commission no later than
90 days after the closing date, or if the registration statement is not declared
effective within 150 days after the closing date (180 days if the registration
statement is reviewed by the Commission), we are required to pay to Stillwater
LLC, as partial liquidated damages, for each month that the registration
statement has not been filed or declared effective, as the case may be, a cash
amount equal to 1% of the liquidated value of the Stillwater Note.
The
following are the risks associated with the July 2006 Note Purchase
Agreements:
THERE
ARE A LARGE NUMBER OF SHARES UNDERLYING OUR SECURED CONVERTIBLE NOTES AND
WARRANTS THAT MAY BE AVAILABLE FOR FUTURE SALE AND THE SALE OF THESE SHARES
MAY
DEPRESS THE MARKET PRICE OF OUR COMMON STOCK.
As
of
August 1, 2006, we had 100,522,492 shares of common stock issued and
outstanding, senior secured convertible notes outstanding that may be converted
into an estimated 23,038,454 shares of common stock at $.26 and outstanding
warrants to purchase 37,404,461 shares of common stock and options to purchase
11,715,754shares. All of the shares issuable upon conversion of the secured
convertible notes and upon exercise of our warrants and options, may be sold
without restriction. Sales of significant amounts of common stock in the public
market, or the perception that such sales may occur, could materially affect
the
market price of our common stock. These sales might also make it more difficult
for us to sell equity or equity-related securities in the future at a time
and
price that we deem appropriate.
THE
ISSUANCE OF SHARES UPON CONVERSION OF THE SECURED CONVERTIBLE NOTES AND EXERCISE
OF OUTSTANDING WARRANTS MAY CAUSE IMMEDIATE AND SUBSTANTIAL DILUTION TO OUR
EXISTING STOCKHOLDERS.
The
issuance of shares upon conversion of the secured convertible notes and exercise
of warrants may result in substantial dilution to the interests of other
stockholders. Although certain of the selling stockholders may not convert
their
secured convertible notes and/or exercise their warrants if such conversion
or
exercise would cause such stockholder to own more than 9.99% of our outstanding
common stock, this restriction does not prevent each of such selling
stockholders from converting and/or exercising and selling some of its holdings
and then converting the rest of its holdings. In this way, such selling
stockholders could sell more than this limit while never holding more than
this
limit.
IF
WE ARE REQUIRED FOR ANY REASON TO REPAY OUR OUTSTANDING SECURED CONVERTIBLE
NOTES, WE WOULD BE REQUIRED TO DEPLETE OUR WORKING CAPITAL, IF AVAILABLE, OR
RAISE ADDITIONAL FUNDS. OUR FAILURE TO REPAY THE SECURED CONVERTIBLE NOTES,
IF
REQUIRED, COULD RESULT IN LEGAL ACTION AGAINST US, WHICH COULD REQUIRE THE
SALE
OF SUBSTANTIAL ASSETS.
In
July
2006, we entered into Note Purchase Agreements for the sale of an aggregate
of
$5,970,000 principal amount of secured convertible notes. 50% of the
aggregate principle amount of each secured convertible note matures 1
year after the date of issuance and the remaining 50% matures 18 months after
the date of issuance, unless sooner converted into shares of our common stock.
In addition, the secured convertible notes pay 6% interest per annum. Any event
of default such as our failure to repay the principal or interest when due,
our
failure to issue shares of common stock upon conversion by the holder, our
failure to timely file a registration statement or have such registration
statement declared effective, breach of any covenant, representation or warranty
in the Note Purchase Agreements or related convertible note, the assignment
or
appointment of a receiver to control a substantial part of our property or
business, the commencement of a bankruptcy, insolvency, reorganization or
liquidation proceeding against our company and the delisting of our common
stock
could require the early repayment of the secured convertible notes, including
a
default interest rate of 12% on the outstanding principal balance of the notes
if the default is not cured within the specified grace period. We anticipate
that the full amount of the secured convertible notes will be converted into
shares of our common stock, in accordance with the terms of the secured
convertible notes. If we were required to repay the secured convertible notes,
we would be required to use our limited working capital and raise additional
funds. If we were unable to repay the notes when required, the note holders
could commence legal action against us and foreclose on all of our assets to
recover the amounts due. Any such action would require us to curtail or cease
operations.
IF
AN EVENT OF DEFAULT OCCURS UNDER THE NOTE PURCHASE AGREEMENTS, SECURED
CONVERTIBLE NOTES, WARRANTS, SECURITY AGREEMENT OR PATENT AND TRADEMARK SECURITY
AGREEMENT, THE INVESTORS COULD TAKE POSSESSION OF ALL OUR GOODS, INVENTORY,
CONTRACTUAL RIGHTS AND GENERAL INTANGIBLES, RECEIVABLES, DOCUMENTS, INSTRUMENTS,
CHATTEL PAPER, AND INTELLECTUAL PROPERTY.
In
connection with the Note Purchase Agreements we entered into in July 2006,
we
executed a Security Agreement, a Patent and Trademark Security Agreement and
a
Lockbox Agreement, each in favor of the investors granting them a first priority
security interest in all of our goods, inventory, contractual rights and general
intangibles, receivables, documents, instruments, chattel paper, and
intellectual property. The Security Agreement, Patent and Trademark Security
Agreement and Lockbox Agreement state that if an event of default occurs under
the Note Purchase Agreements, Secured Convertible Notes, Warrants, Security
Agreement, Patent and Trademark Security Agreement or Lockbox Agreement, the
investors have the right to take possession of the collateral, to operate our
business using the collateral, and have the right to assign, sell, lease or
otherwise dispose of and deliver all or any part of the collateral, at public
or
private sale or otherwise to satisfy our obligations under these
agreements.
Potential
Disadvantages to the Reverse Stock Split
Reduced
Market Capitalization.
As
noted above, the principal purpose of the reverse stock split would be to help
maintain the price of our common stock at a higher level. We cannot assure
you
that the reverse stock split will accomplish this objective. While we expect
that the reduction in our outstanding shares of common stock will increase
the
market price of our common stock, we cannot assure you that the reverse stock
split will increase the market price of our common stock by a multiple equal
to
the number of pre-split shares in the reverse split ratio determined by the
board of directors, which will be ten, or result in any permanent increase
in
the market price, which can be dependent upon many factors, including our
business and financial performance and prospects. Should the market price
decline after the reverse stock split, the percentage decline may be greater,
due to the smaller number of shares outstanding, than it would have been prior
to the reverse stock split. In some cases the stock price of companies that
have
effected reverse stock splits has subsequently declined back to pre-reverse
split levels. Accordingly, we cannot assure you that the market price of our
common stock immediately after the effective date of the proposed reverse stock
split will be maintained for any period of time or that the ratio of post and
pre-split shares will remain the same after the reverse stock split is effected,
or that the reverse stock split will not have an adverse effect on our stock
price due to the reduced number of shares outstanding after the reverse stock
split. A reverse stock split is often viewed negatively by the market and,
consequently, can lead to a decrease in our overall market capitalization.
If
the per share price does not increase proportionately as a result of the reverse
stock split, then our overall market capitalization will be
reduced.
Increased
Transaction Costs.
The
number of shares held by each individual stockholder will be reduced if the
reverse stock split is implemented. This will increase the number of
stockholders who hold less than a "round lot," or 100 shares. Typically, the
transaction costs to stockholders selling "odd lots" are higher on a per share
basis. Consequently, the reverse stock split could increase the transaction
costs to existing stockholders in the event they wish to sell all or a portion
of their position.
Liquidity.
Although the board believes that the decrease in the number of shares of our
common stock outstanding as a consequence of the reverse stock split and the
anticipated increase in the price of our common stock could encourage interest
in our common stock and possibly promote greater liquidity for our stockholders,
such liquidity could also be adversely affected by the reduced number of shares
outstanding after the reverse stock split.
Effect
on Fractional Shares
A
reverse
stock split would result in some stockholders owning a fractional share of
common stock. For example, in a 1-for-10 reverse stock split, the shares owned
by a stockholder with 112 shares would be converted into 11.2 shares. In lieu
of
issuing fractional shares, the Company will issue to any shareholder who
otherwise would have been entitled to receive a fractional share as a result
of
the reverse split an additional full share of its common stock.
Effect
of Reverse Stock Split on Options
The
number of shares subject to outstanding options to purchase shares of our common
stock also would automatically be reduced in the same ratio as the reduction
in
the outstanding shares. Correspondingly, the per share exercise price of those
options will be increased in direct proportion to the reverse stock split ratio,
so that the aggregate dollar amount payable for the purchase of the shares
subject to the options will remain unchanged. For example, a 1-for-10 reverse
stock split is implemented and an optionee holds options to purchase 1,000
shares at an exercise price of $0.66 per share. On the effectiveness of the
1-for-10 reverse stock split, the number of shares subject to that option would
be reduced to 100 shares and the exercise price would be proportionately
increased to $6.60 per share.
Effect
of Reverse Stock Split on Warrants
The
agreements governing the outstanding warrants to purchase shares of our common
stock include provisions requiring adjustments to both the number of shares
issuable upon exercise of such warrants, and the exercise prices of such
warrants, in the event of a reverse stock split. For example, assume that a
1-for-10 reverse stock split is implemented and a warrant holder holds a warrant
to purchase 10,000 shares of our common stock at an exercise price of $.75
per
share. On the effectiveness of the reverse stock split, the number of shares
subject to that warrant would be reduced to 1,000 shares and the exercise price
would be proportionately increased to $7.50 per share.
Implementation
and Effect of the Reverse Stock Split
If
approved by our stockholders at the annual meeting that effecting a reverse
stock split at a 1-for-10 ratio is in our best interests and the best interests
of our stockholders. Following such determinations, the board will effect the
reverse stock split by directing management to file the certificate of amendment
with the Delaware Secretary of State. The reverse stock split will become
effective at the time specified in the certificate of amendment after the filing
of the amendment with the Delaware Secretary of State, which we refer to as
the
“effective time”.
We
estimate that, following the reverse stock split, we would have approximately
the same number of stockholders and the completion of the reverse stock split
would not affect any stockholder's proportionate equity interest in our company.
By way of example, a stockholder who owns a number of shares that prior to
the
reverse stock split represented one-half of a percent of the outstanding shares
of the company would continue to own one-half of a percent of our outstanding
shares after the reverse stock split. The reverse stock split also will not
affect the number of shares of common stock that our board of directors is
authorized to issue under our amended and restated certificate of incorporation,
which will remain unchanged at 200,000,000 shares. However, it will have the
effect of increasing the number of shares available for future issuance because
of the reduction in the number of shares that will be outstanding after giving
effect to the reverse stock split.
Exchange
of Stock Certificates and Payment for Fractional Shares
Exchange
of Stock Certificates.
Promptly after such an effective time, you would be notified that the reverse
stock split has been effected and the applicable ratio. Our stock transfer
agent, Continental Stock Transfer & Trust Company, whom we refer to as the
“exchange agent”, would implement the exchange of stock certificates
representing outstanding shares of common stock. You would be asked to surrender
to the exchange agent certificates representing your pre-split shares in
exchange for certificates representing your post-split shares in accordance
with
the procedures to be set forth in a letter of transmittal which we would send
to
you. You would not receive a new stock certificate representing your post-split
shares until you surrender your outstanding certificate(s) representing your
pre-split shares, together with the properly completed and executed letter
of
transmittal to the exchange agent. We would not issue scrip or fractional
shares, or certificates for fractional shares, in connection with the reverse
stock split. Should you be entitled to receive fractional shares because you
hold a number of shares not evenly divisible by the reverse split number which
will be ten, you will be entitled, upon surrender to the exchange agent of
certificates representing such shares, to receive an additional full share
of
common stock.
IF
THIS REVERSE SPLIT WERE TO BE EFFECTED, PLEASE DO NOT DESTROY ANY STOCK
CERTIFICATE OR SUBMIT ANY OF YOUR CERTIFICATES UNTIL YOU ARE REQUESTED TO DO
SO.
Effect
of Failure to Exchange Stock Certificates.
Upon
the filing of the amendment to our certificate of incorporation with the
Delaware Secretary of State, each certificate representing shares of our common
stock outstanding prior to the that time would, until surrendered and exchanged
as described above, be deemed, for all corporate purposes, to evidence ownership
of the whole number of shares of our common stock. However, a holder of such
unexchanged certificates would not be entitled to receive any dividends or
other
distributions payable by us after the effective date, until the old certificates
have been surrendered. Such dividends and distributions, if any, would be
accumulated, and at the time of surrender of the old certificates, all such
unpaid dividends or distributions will be paid without interest.
No
Appraisals Rights
Under
the
Delaware General Corporation Law and our certificate of incorporation and
bylaws, you are not entitled to appraisal rights with respect to the reverse
stock split.
Federal
Income Tax Consequences
The
following description of the material federal income tax consequences of the
reverse stock split is based on the Internal Revenue Code, applicable Treasury
Regulations promulgated under the Code, judicial authority and current
administrative rulings and practices as in effect on the date of this proxy
statement. Changes to the laws could alter the tax consequences described below,
possibly with retroactive effect. We have not sought and will not seek an
opinion of counsel or a ruling from the Internal Revenue Service regarding
the
federal income tax consequences of any of the proposed reverse stock splits.
This discussion is for general information only and does not discuss the tax
consequences that may apply to special classes of taxpayers (e.g., non-resident
aliens, broker/dealers or insurance companies). The state and local tax
consequences of the reverse stock split may vary significantly as to each
stockholder, depending upon the jurisdiction in which such stockholder resides.
We urge stockholders to consult their own tax advisors to determine the
particular consequences to them.
We
believe that because the reverse stock split is not part of a plan to increase
periodically a stockholder's proportionate interest in our assets or earnings
and profits, the reverse stock split will likely have the following federal
income tax effects.
A
stockholder who receives solely a reduced number of shares of our common stock
will not recognize gain or loss. In the aggregate, such a stockholder's basis
in
the reduced number of shares of our common stock will equal the stockholder's
basis in its old shares of common stock and the holding period of the common
stock received after the reverse stock split will include the holding period
of
the common stock held prior to the reverse stock split exchanged
therefore.
We
will
not recognize any gain or loss as a result of the reverse stock
split.
Required
Vote
Authorizing
the Company's Board of Directors, in its discretion, to amend the Company's
certificate of incorporation to effect the reverse stock split requires the
affirmative vote of the holders of at least a majority of the shares of common
stock present in person or represented by proxy at the Annual Meeting.
RECOMMENDATION
OF THE BOARD FOR PROPOSAL NO. 3:
THE
BOARD RECOMMENDS A VOTE FOR APPROVAL OF THE REVERSE STOCK
SPLIT.
ITEM
4
THE
POTENTIAL ISSUANCE OF SHARES OF OUR COMMON STOCK UNDERLYING SECURITIES
CONVERTIBLE OR EXERCISABLE INTO COMMON STOCK AT A PRICE BELOW FAIR MARKET VALUE
IF THE CONVERSION AND EXERCISE PRICES OF SUCH SECURITIES ARE ADJUSTED TO A
PRICE
BELOW FAIR MARKET VALUE
We
are
seeking our stockholders' approval, to the extent required by the American
Stock
Exchange ("AMEX"), to potentially issue shares of our common stock underlying
our 6% Senior Secured Convertible Notes Due 2007-2008 and warrants to purchase
shares of our common stock, at a price below fair market value at the time
of
issuance and sale.
On
July
21, 2006, we entered into several Note Purchase Agreements (the “Purchase
Agreements”) to sell to certain qualified institutional buyers and accredited
investors up to $5,970,000 in principal amount 6% Senior Secured Convertible
Notes Due 2007-2008 (the “Notes”), together with warrants to purchase 16,073,067
shares of our common stock, par value $0.001 per share. In addition, on the
same
date, we entered into an additional Note Purchase Agreement with Stillwater
LLC
which provides for the purchase and sale of an additional Note in the principal
amount of up to $500,000 (the “Stillwater Note”), together with a warrant (the
“Stillwater Warrant”) to purchase 70% of the number of shares issuable upon
conversion of the Stillwater Note, at our sole discretion by delivery of a
notice to Stillwater LLC on December 14, 2006 for the completion of the purchase
and sale to occur on December 29, 2006 (the "Closing Date"). Our ability to
require Stillwater LLC to purchase and pay for the Stillwater Note and
Stillwater Warrant shall be reduced by the sum of (i) the additional financing
raised by us prior to the Closing Date, and (ii) the aggregate exercise price
paid by Stillwater LLC to us upon exercise of all or a portion of any of our
common stock purchase warrants owned by Stillwater LLC prior to the Closing
Date, including a warrant to purchase 1,923,077 shares of our common stock
which we issued to Stillwater LLC on July 21, 2006 (the “July
Warrant”).
The
Notes
are convertible into shares of our common stock at a price equal to $.26 (100%
of the market price of the common stock on July 20, 2006) and the Warrants
are
exercisable into common stock at $.36 per share (100% of the market price of
the
common stock on July 20, 2006, plus
$.10).
The conversion price of the Stillwater Note shall be equal to 100% of the market
price of the common stock on December 13, 2006 and the exercise price of the
Stillwater Warrant will be equal to 100% of the market price of the common
stock
on December 13, 2006, plus $0.10. In addition, the exercise price of the July
Warrant issued to Stillwater LLC is $.26 per share (100% of the market price
of
the common stock on July 20, 2006). The aforementioned conversion and exercise
prices are subject to adjustment in the event that our Chief Executive Officer,
Chief Financial Officer or Chief Strategy Officer sells, transfers or disposes
of shares of common stock or securities convertible into our common stock,
other
than 50,000 shares of common stock in any fiscal quarter which our Chief
Financial Officer is permitted to sell on or after January 1, 2007. In such
event the conversion and exercise prices shall be reduced, if applicable, to
a
price equal to the average of the daily volume weighted average prices for
each
of the three trading days following the date such sale, transfer or disposition
is reported, or required to be reported, on a Form 4 filing with the Securities
and Exchange Commission.
If
our
Chief Executive Officer, Chief Financial Officer or Chief Strategy Officer
sells, transfers or disposes of shares of common stock or securities convertible
into our common stock and the adjustment provision is triggered as set forth
above, the conversion and exercise prices of the Notes, Warrants, Stillwater
Notes, Stillwater Warrants and the July Warrant could be adjusted to a price
below the fair market value on the day in which we are required to issue common
stock underlying said securities.
Under
Section 713 of the Listing Standards, Policies and Requirements of the
AMEX, the sale, issuance, or potential issuance by a company of common stock
(or
securities convertible into common stock) equal to 20% or more of presently
outstanding stock for less than the greater of book or market value of our
stock
requires stockholder approval, provided that stockholder approval is not
required for a "public offering" as defined by the AMEX.
Required
Vote
The
vote
required to approve the issuance of our common stock as proposed is a majority
of the shares present in person or by proxy and entitled to vote at the Annual
Meeting. If this proposal is not approved, any issuance requiring such approval
will not be made, although further approvals may be sought. If the issuances
are
approved we do not intend to solicit the further approval of our stockholders
for any issuance as to which the required approval remains in
effect.
RECOMMENDATION
OF THE BOARD FOR PROPOSAL NO. 4:
THE
BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR THE POTENTIAL ISSUANCE
OF
SHARES OF OUR COMMON STOCK UNDERLYING SECURITIES CONVERTIBLE OR EXERCISABLE
INTO
COMMON STOCK AT A PRICE BELOW FAIR MARKET VALUE IF THE CONVERSION AND EXERCISE
PRICES OF SUCH SECURITIES ARE ADJUSTED TO A PRICE BELOW FAIR MARKET
VALUE.
INCREASE
OF THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK ISSUABLE PURSUANT TO THE
2004
NON-EMPLOYEE COMPENSATION PLAN
At
the
Annual Meeting, the Company's stockholders are being asked to approve an
increase in the number of authorized shares of common stock issuable pursuant
to
the 2004 Non-Employee Compensation Plan ("2004 Non-Employee Compensation Plan")
from 2,000,000 to 9,500,000 shares. The Board has unanimously approved such
increase and has directed that it be submitted for the approval of the
stockholders at the annual meeting. The increase in the number of authorized
shares of common stock issuable pursuant to the 2004 Non-Employee Compensation
Plan from 2,000,000 to 9,500,000 shares will become effective on the date of
shareholder approval (the "Effective Date").
The
following description of the 2004 Non-Employee Compensation Plan is only a
summary of the important provisions of the 2004 Non-Employee Compensation Plan
and does not contain all of the terms and conditions of the 2004 Non-Employee
Compensation Plan. A copy of the 2004 Non-Employee Compensation Plan is attached
to this Proxy Statement as “Appendix B”.
What
Is the Purpose of the 2004 Non-Employee Compensation Plan?
The
purpose of the 2004 Non-Employee Compensation Plan is to help us retain
consultants, professionals, and service providers who provide services to the
Company in connection with, among other things, the Company's obligations as
a
publicly-held reporting company. In addition, we expect to benefit from the
added interest that the awardees will have in our welfare as a result of their
ownership or increased ownership of our Common Stock.
Over
the
last two years, we have been able to engage consultants, professionals, and
service providers by compensating them through the issuance of shares of our
common stock. This afforded us the ability to utilize our cash, at a time when
we were seeking out financing and working with our creditors with respect to
restructuring outstanding obligations, for the more immediate needs that we
had
related to the acquisition of the products and inventory needed to further
our
manufacturing process so as to be able to deliver finished goods to our
customers pursuant to outstanding orders. The cost of capital obtained through
these supplier and strategic stock issuances has typically been much less than
the cost of capital obtained through private placements as warrant issuances
and
expenses of a capital raise are typically much lower. We believe that, for
the
foreseeable future, it is in our best interests to be able to continue to engage
and compensate such persons through the payment of our shares of common stock.
In addition, Section 711 of the AMEX Company Guide, which was amended in October
2003, now requires that such compensation arrangements be approved by the
Company's shareholders. For the foregoing reasons, the Board of Directors has
unanimously approved the increase in the number of authorized shares of common
stock issuable pursuant to the 2004 Non-Employee Compensation Plan from
2,000,000 to 9,500,000 shares and has directed that such proposal be submitted
for the approval of the stockholders at the annual meeting.
What
Types of Awards Can be Granted Under the 2004 Non-Employee Compensation
Plan?
Awards
authorized under the 2004 Non-Employee Compensation Plan shall consist of shares
of our common stock. Such awards may be subject to forfeiture in the event
of
premature termination of engagement, failure to meet certain performance
objectives, or other conditions, as may be determined by the Board of
Directors.
Each
award described above is sometimes referred to in this Proxy Statement as an
"Award", and all such awards are sometime collectively referred to in this
Proxy
Statement as "Awards" and individuals receiving Awards are sometimes referred
to
as "Awardees".
How
Will the 2004 Non-Employee Compensation Plan Be
Administered?
The
2004
Non-Employee Compensation Plan will be administered by the Board of Directors
(provided however, that the Board may delegate such administration to the
Compensation Committee). Subject to the express terms and conditions of the
2004
Non-Employee Compensation Plan, the Board of Directors will have full power
to
make Awards, to construe or interpret the 2004 Non-Employee Compensation Plan,
to prescribe, amend and rescind rules and regulations relating to it and to
make
all other determinations necessary or advisable for its administration. Except
as otherwise provided in the 2004 Non-Employee Compensation Plan, the Board
of
Directors may also determine which persons shall be granted Awards, the nature
of the Awards granted, the number of shares subject to Awards and the time
at
which Awards shall be made. Such determinations will be final and
binding.
How
Much Stock Will Be Available Under the 2004 Non-Employee Compensation
Plan?
The
only
class of stock subject to an Award is Common Stock. The maximum number of shares
of Common Stock with respect to which Awards may be granted is currently
2,000,000 shares of which 90% have been distributed over the past two years
under the plan; however, this number is subject to adjustment in the event
of a
recapitalization, reorganization or similar event. If our stockholders approve
this Proposal 4, the maximum number of shares of Common Stock with respect
to
which Awards may be granted will be 9,500,000 shares.
Shares
shall consist, in whole or in part, of authorized and unissued shares or
treasury shares. Any shares represented by Awards that are cancelled, forfeited,
terminated or expired will again be available for grants and issuance under
the
2004 Non-Employee Compensation Plan.
Who
Is Eligible to Participate in the 2004 Non-Employee Compensation
Plan?
Persons
eligible for Awards under the 2004 Non-Employee Compensation Plan will be
limited to consultants, professionals and service providers of the Company
and
our subsidiaries ("Eligible Persons"). The Board of Directors will select who
will receive Awards and the amount and nature of such Awards.
What
Happens If the Number of Outstanding Shares Changes Because of a Merger,
Consolidation, Recapitalization or Reorganization?
In
the
event that our outstanding shares of Common Stock are increased, decreased
or
changed or converted into other securities by reason of merger, reorganization,
consolidation, recapitalization, stock dividend, extraordinary cash dividend
or
other change in our corporate structure affecting the stock, the number of
shares that may be delivered under the 2004 Non-Employee Compensation Plan
and
the number and/or the purchase price of shares subject to outstanding Awards
under the 2004 Non-Employee Compensation Plan may be adjusted at the sole
discretion of the Board of Directors to the extent that the Board of Directors
determines to be appropriate, provided, however, that the number of shares
subject to any Awards will always be a whole number.
When
Will the 2004 Non-Employee Compensation Plan Terminate?
The
2004
Non-Employee Compensation Plan will expire on May 17, 2014, but the Board of
Directors may terminate the 2004 Non-Employee Compensation Plan at any time
prior to that date and Awards granted prior to such termination may extend
beyond such date. Termination of the 2004 Non-Employee Compensation Plan will
not alter or impair, without the consent of the Awardee, any of the rights
or
obligations of any Award made under the 2004 Non-Employee Compensation
Plan.
What
Changes Can the Board Make to the 2004 Non-Employee Compensation
Plan?
The
Board
may from time to time alter, amend, suspend or discontinue the 2004 Non-Employee
Compensation Plan. However, no such action of the Board may alter the provisions
of the 2004 Non-Employee Compensation Plan so as to alter any outstanding Awards
to the detriment of the Awardee or participant without such participant's or
Awardees consent, and no amendment to the 2004 Non-Employee Compensation Plan
may be made without stockholder approval if such amendment would materially
increase the benefits to the Awardees or the participants in the 2004
Non-Employee Compensation Plan, materially increase the number of shares
issuable under the 2004 Non-Employee Compensation Plan, extend the terms of
the
2004 Non-Employee Compensation Plan or the period during which Awards may be
granted or exercised or materially modify requirements as to eligibility to
participate in the 2004 Non-Employee Compensation Plan.
What
Are the Important Provisions of the Plan With Respect to Each Type of
Award?
Grant.
The
Board of Directors may, at its discretion, award shares of common stock to
a
recipient (the "Stock Awards"). The Stock Awards will be issued pursuant to
an
agreement between the Company and the Awardee. Each recipient of a Stock Award
will be a stockholder and have all the rights of a stockholder with respect
to
such shares, including the right to vote and receive all dividends or other
distributions made or paid with respect to such shares.
If
the
recipient of an Award ceases to be a consultant, professional or service
provider for any reason, then the Award may be subject to forfeiture, as
provided in the particular agreement, unless such forfeiture is waived by the
Board of Directors when it, in its discretion, determines that such waiver
is in
our best interests.
In
the
event of a participant's retirement, permanent disability or death, or in cases
of special circumstances, the Board of Directors may waive any or all of the
remaining restrictions and limitations imposed under the 2004 Non-Employee
Compensation Plan with respect to any Awards.
Restrictions
on Transferability.
These
Shares of stock may not be sold, exchanged, transferred, pledged, hypothecated,
or otherwise disposed of until such time as any stated restrictions lapse.
The
Board of Directors, in its absolute discretion, may impose such restrictions
on
the transferability of the Awards granted in this 2004 Non-Employee Compensation
Plan as it deems appropriate. Any such restrictions shall be set forth in the
Agreement with respect to such Awards and may be referred to on the certificates
evidencing shares issued pursuant to any such Award. Shares of restricted stock
will be evidenced by a certificate that bears a restrictive legend.
What
are the U.S. Federal Income Tax Consequences of the 2004 Non-Employee
Compensation Plan?
The
following discussion is a summary of the U.S. Federal income tax consequences
to
recipients of Awards and to us with respect to Awards granted under the 2004
Non-Employee Compensation Plan. The 2004 Non-Employee Compensation Plan is
not
qualified under Section 401(a) of the Code.
Stock
awarded to an Awardee may be subject to any number of restrictions (including
deferred vesting, limitations on transfer, and forfeit ability) imposed by
the
Board of Directors. In general, the receipt of stock with restrictions will
not
result in the recognition of income by an Awardee until such time as the shares
are either not forfeitable or are freely transferable. Upon the lapse of such
restrictions, the Awardee will be required to include as ordinary income the
difference between the amounts paid for the stock, if any, and the fair market
value of such stock on the date the restrictions lapse and we will be entitled
to a corresponding deduction. In addition, any dividends paid with respect
to
the stock prior to the lapse of the restrictions will be treated as compensation
income by the Awardee and will be deductible by us. Awardees receiving Stock
Awards may elect to include the value of such stock (less any amounts paid
for
such stock) as ordinary income at the time the Award is made. Awardees making
this election would treat any gain or loss realized on a sale of the stock
as
capital gain or loss, but would not be entitled to any loss deduction if they
forfeited the stock pursuant to the restrictions imposed by the Board of
Directors.
In
view
of the complexity of the tax aspects of transactions involving the grant and
exercise Awards, and because the impact of taxes will vary depending on
individual circumstances, each Awardee receiving an Award under the 2004
Non-Employee Compensation Plan should consult their own tax advisor to determine
the tax consequences in such Awardee's particular circumstances.
Registration
with the Securities and Exchange Commission
We
intend
to file a Post-Effective Registration Statement on Form S-8 covering the
increase in shares of common stock issuable pursuant to the 2004 Non-Employee
Compensation Plan if such increase is approved by the Company’s
stockholders.
Required
Vote
Approving
of the increase in the number of authorized shares of common stock issuable
pursuant to the 2004 Non-Employee Stock Compensation Plan from 2,000,000 to
9,500,000 shares requires the affirmative vote of the holders of at least a
majority of the shares of common stock present in person or represented by
proxy
at the Annual Meeting.
RECOMMENDATION
OF THE BOARD FOR PROPOSAL NO. 5:
THE
BOARD RECOMMENDS A VOTE FOR APPROVAL OF
AN
INCREASE OF THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK ISSUABLE
PURSUANT
THE
2004 NON-EMPLOYEE COMPENSATION PLAN.
ITEM
6
RATIFICATION
OF THE
APPOINTMENT
OF INDEPENDENT AUDITORS
Eisner
LLP, independent auditors, audited the financial statements of eMagin
Corporation for the 2005 fiscal year. Representatives of Eisner LLP are expected
to attend the Annual Meeting of stockholders and will have the opportunity
to
make a statement if they desire to do so and are expected to be available to
answer appropriate questions. The Audit Committee and the Board of Directors
have selected Eisner LLP as the independent auditors of the Company for the
fiscal year ending December 31, 2006.
In
connection with the standards for independence of the Company’s independent
auditors promulgated by the Securities and Exchange Commission, the Audit
Committee has considered whether the provision of such services is compatible
with maintaining the independence of Eisner LLP and has determined that such
services are compatible with the continued independence of Eisner
LLP.
The
appointment of the Company's independent auditors requires the receipt of the
affirmative vote of a majority of the shares of the Company's common stock
present in person or by proxy and voting at the Annual Meeting. For purposes
of
determining the number of shares voting, only votes cast "for" or "against"
are
included. Abstentions and broker non-votes are not included.
Audit
Fees
For
the
years ended December 31, 2005 and 2004, the aggregate fees payable to Eisner
LLP
for professional services rendered for the audit of the annual financial
statements, review of quarterly financial statements and services normally
provided in connection with statutory and regulatory filings or engagements
were
approximately $151,000 and $136,000, respectively.
There
were no other fees billed for services rendered to the Company by Eisner LLP,
other than fees for audit and audit-related, for the years 2005 and 2004. Eisner
LLP did not perform any services which directly or indirectly related to the
operation of, or supervision of the operation of, our information systems or
management of our local area network.
Required
Vote
The
appointment of the Company's independent auditors requires the receipt of the
affirmative vote of a majority of the shares of the Company's common stock
present in person or by proxy and voting at the Annual Meeting.
RECOMMENDATION
OF THE BOARD FOR PROPOSAL NO. 6:
THE
BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE RATIFICATION OF THE APPOINTMENT
OF
EISNER LLP AS THE INDEPENDENT AUDITORS OF THE COMPANY.
OTHER
MATTERS
The
Board
of Directors knows of no other business which will be presented at the Annual
Meeting. If any other matters properly come before the meeting, the persons
named in the enclosed Proxy and will vote the shares represented thereby in
accordance with their judgment on such matters.
Annual
Reports and Form 10-K.
Additional
copies of eMagin's Annual Report and Form 10-K for the fiscal years ended
December 31, 2005 may be obtained without charge by writing to the Secretary,
eMagin Corporation, 10500 NE 8th
St.,
Suite 1400, Bellevue, WA 98004. eMagin's Annual Report and Form 10-K can also
be
found on eMagin's website: www.eMagin.com.
Stockholders
Proposals for the 2007 Annual Meeting.
Stockholders
who wish to submit proposals pursuant to Rule 14a-8 of the 1934 Act for
inclusion in the Proxy Statement for the Company's 2007 Annual Meeting of
Stockholders must submit the same to the Secretary, at the Company's principal
executive office at 10500 NE 8th
St.,
Bellevue, WA 98004 no later than January 15, 2007.
Proxy
Solicitation Costs.
The
proxies being solicited hereby are being solicited by the Company. The Company
will bear the entire cost of solicitation of proxies, including preparation,
assembly, printing and mailing of this Proxy Statement, the Proxy card and
any
additional information furnished to stockholders. Copies of solicitation
materials will be furnished to banks, brokerage houses, fiduciaries and
custodians holding in their names shares of common stock beneficially owned
by
others to forward to such beneficial owners. We have retained Georgeson
Shareholder Communications, Inc. 17 State Street, New York, New York 10004,
to
aid in the solicitation. For these services, we will pay Georgeson a fee of
$13,000 and reimburse it for certain out-of-pocket disbursements and expenses.
Officers and regular employees of the Company may, but without compensation
other than their regular compensation, solicit proxies by further mailing or
personal conversations, or by telephone, telex, facsimile or electronic means.
We will, upon request, reimburse brokerage firms and others for their reasonable
expenses in forwarding solicitation material to the beneficial owners of
stock.
|
|
|
|
By
Order of the Board of Directors,
|
|
|
|
|
|
/s/ Susan
K. Jones |
|
Susan
K. Jones |
|
Executive
Vice
President and Secretary |
APPENDIX
A
AMENDED
AND RESTATED CERTIFICATE OF INCORPORATION
OF
EMAGIN
CORPORATION
a
Delaware Corporation
(Incorporated
under the name
FED
Corporation on November 30, 1993)
EMAGIN
CORPORATION,
a
corporation organized and existing under and by virtue of the General
Corporation Law of the State of Delaware (the "DGCL"), incorporated under the
name "FED Corporation" on November 30, 1993, DOES
HEREBY CERTIFY THAT:
FIRST:
The
Board of Directors of the Corporation, by unanimous written consent pursuant
to
section 141(f) of the DGCL, duly adopted resolutions proposing and approving
the
Amended and Restated Certificate of Incorporation of the Corporation, declaring
its advisability and directing that such Amended and Restated Certificate of
Incorporation be submitted to the stockholders of the Corporation to consider
and adopt the same.
SECOND:
Pursuant to Section 228 of the DGCL, the adoption of the Amended and Restated
Certificate of Incorporation was consented to in writing by a majority of the
holders of the voting power of all shares of capital stock of the Corporation
entitled to vote thereon, and by a majority of the holders of each outstanding
class of capital stock of the Corporation entitled to vote thereon.
THIRD:
The
Amended and Restated Certificate of Incorporation was duly adopted in accordance
with the provisions of the DGCL.
FOURTH:
Pursuant to Sections 245(b) and 242 of the DGCL, the Certificate of
Incorporation, as amended, of eMagin Corporation, a Delaware corporation (the
"Corporation"), is hereby restated and amended to read in its entirety as
follows:
AMENDED
AND RESTATED
CERTIFICATE
OF INCORPORATION
ONE:
Name.
The name of the Corporation is "eMagin Corporation".
TWO:
Registered Agent. The registered office of the Corporation in the State of
Delaware is located at 1209 Orange Street in the City of Wilmington and the
County of Newcastle. The name of the registered agent of the Corporation in
the
State of Delaware at such address is the Corporation Trust Company.
THREE:
Purpose. The purpose of the Corporation is to engage, directly or indirectly,
in
any lawful act or activity for which corporations may be organized under the
General Corporation Law of the State of Delaware as from time to time in
effect.
FOUR:
Capital
Stock. The total authorized capital stock of the Corporation shall be
210,000,000 shares consisting of 200,000,000 shares of Common Stock, par value
$0.001 per share and 10,000,000 shares of Series Preferred Stock, par value
$0.001 per share. Upon the filing and effectiveness (the "Effective Time")
of
this Amended and Restated Certificate of Incorporation with the Delaware
Secretary of State, every ten outstanding shares of Common Stock shall without
further action by this Corporation or the holder thereof be combined into and
automatically become one share of Common Stock. The number of authorized shares
of Common Stock of the Corporation and the par value of the Common Stock shall
remain as set forth in this Certificate of Incorporation, as amended. No
fractional share shall be issued in connection with the foregoing combination.
All fractional shares shall be rounded up to the next whole number of shares.
The capital of the Corporation will not be reduced under or by reason of any
amendment herein certified.
The
preferences, relative, participating, optional or other special rights,
qualifications, limitations, restrictions, voting powers and privileges of
each
class of the Corporation's capital stock shall be as follows:
A.
Series Preferred Stock.
The
Series Preferred Stock may be issued in one or more series as shall from time
to
time be created and authorized to be issued by the Board of Directors as
hereinafter provided.
(a)
The
Board of Directors is hereby expressly authorized, by resolution or resolutions
from time to time adopted providing for the issuance of any series of the Series
Preferred Stock, to the extent not fixed by the provisions hereinafter set
forth
or otherwise provided by law, to determine that any series of the Series
Preferred Stock shall be without voting powers and to fix and state the voting
powers, full or limited, if any, the designations, powers, preferences and
relative, participating, optional and other special rights, if any, of the
shares of each series of the Series Preferred Stock, and the qualifications,
limitations and restrictions thereof, including (but without limiting the
generality of the foregoing) any of the following:
(1)
the
number of shares to constitute such series and the distinctive name and serial
designation thereof;
(2)
the
annual dividend rate or rates and the date on which the first dividend on shares
of such series shall be payable and all subsequent dividend payment
dates;
(3)
whether dividends are to be cumulative or non-cumulative, the participating
or
other special rights, if any, with respect to the payment of dividends and
the
date from which dividends on all shares of such series issued prior to the
record date for the first dividend shall be cumulative; provided that, such
dividends shall be cumulative only if and to the extent set forth in a
certificate filed pursuant to law;
(4)
whether any series shall be subject to redemption and, if so, the manner of
redemption and the redemption price or prices for such series, which may consist
of a redemption price or scale of redemption prices applicable only to
redemption for a sinking fund (which terms as used in this clause shall include
any fund or provisions for the periodic purchase or retirement of shares),
and a
different redemption price or scale of redemption prices applicable to any
other
redemption;
(5)
whether or not the shares of such series shall be subject to the operation
of a
purchase, retirement or sinking fund, and, if so, whether such purchase,
retirement or sinking fund shall be cumulative or non-cumulative, the extent
to
and the manner in which such fund shall be applied to the purchase or redemption
of the shares of such series for retirement or for other corporate purposes
and
the terms and provisions relative to the operation thereof;
(6)
the
terms, if any, upon which shares of such series shall be convertible into,
or
exchangeable for, or shall have rights to purchase or other privileges to
acquire shares of stock of any other class or of any other series of the same
or
any other class, including the price or prices or the rate or rates of
conversion, exchange, purchase or acquisition and the terms of adjustment,
if
any;
(7)
the
limitations and restrictions, if any, to be effective while any shares of such
series are outstanding upon the payment of dividends or making of other
distributions on, and upon the purchase, redemption, or other acquisition of,
the Common Stock or any other series or class of stock of the Corporation
ranking junior to the shares of such series, either as to dividends or upon
liquidation; and
(8)
the
conditions or restrictions, if any, upon the creation of indebtedness of the
Corporation or upon the issue of any additional stock of any class (including
additional shares of such series or of any other series of the Series Preferred
Stock) ranking on a parity with or prior to the shares of such series either
as
to dividends or upon liquidation.
(b)
Each
share of each series of the Series Preferred Stock shall have the same relative
rights and be identical in all respects with all the other shares of the same
series, except that shares of any one series issued at different times may
differ as to the dates, if any, from which dividends thereon shall be
cumulative. Except as otherwise provided by law or specified in
this
Article
FOUR any series of the Series Preferred Stock may differ from any other series
with respect to any one or more of the voting powers, designations, powers,
preferences and relative, participating, optional and other special rights,
if
any, and the qualifications, limitations and restrictions thereof.
(c)
Before any dividends on any class of stock of the Corporation ranking junior
to
the Series Preferred Stock (other than dividends payable in shares of any class
of stock of the Corporation ranking junior to the Series Preferred Stock) shall
be declared or paid or set apart for payment, the holders of shares of each
series of the Series Preferred Stock shall be entitled to such cash dividends,
but only when and as declared by the Board of Directors out of funds legally
available therefor, as they may be entitled to in accordance with the resolution
or resolutions adopted by the Board of Directors providing for the issuance
of
such series, payable on such dates as may be fixed in such resolution or
resolutions.
(d)
In
the event of any liquidation, dissolution or winding up of the Corporation,
whether voluntary or involuntary, before any payment or distribution of the
assets of the Corporation shall be made to or set apart for the holders of
shares of any class of stock of the Corporation ranking junior to the Series
Preferred Stock, the holders of the shares of each series of the Series
Preferred Stock shall be entitled to receive payment of the amount per share
fixed in the resolution or resolutions adopted by the Board of Directors
providing for the issuance of the shares of such series, plus an amount equal
to
all dividends accrued thereon to the date of final distribution to such holders.
If, upon any liquidation, dissolution or winding up of the Corporation, the
assets of the Corporation, or proceeds thereof, distributable among the holders
of the shares of the Series Preferred Stock shall be insufficient to pay in
full
the preferential amount aforesaid, then such assets, or the proceeds thereof,
shall be distributed among such holders ratably in accordance with the
respective amounts which would be payable on such shares if all amounts payable
thereon were paid in full. For the purposes of this paragraph (d), the sale,
conveyance, exchange or transfer (for cash, shares of stock, securities or
other
consideration) of all or substantially all of the property or assets of the
Corporation or a consolidation or merger of the Corporation with one or more
corporations shall not be deemed to be a dissolution, liquidation or winding
up,
voluntary or involuntary.
(e)
The
term "junior stock", as used in relation to the Series Preferred Stock, shall
mean the Common Stock and any other class of stock of the Corporation hereafter
authorized which by its terms shall rank junior to the Series Preferred Stock
as
to dividends and as to the distribution of assets on liquidation.
(f)
Before the Corporation shall issue any shares of the Series Preferred Stock
of
any series authorized as hereinbefore provided, a certificate setting forth
a
copy of the resolution or resolutions with respect to such series adopted by
the
Board of Directors of the Corporation pursuant to the foregoing authority vested
in said Board of Directors shall be made, filed and recorded in accordance
with
the then applicable requirements, if any, of the laws of the State of Delaware,
or, if no certificate is then so required, such certificate shall be signed
and
acknowledged on behalf of the Corporation by its President or a Vice-President
and attested by its Secretary or an Assistant Secretary and such certificate
shall be filed and kept on file at the registered office of the Corporation
in
the State of Delaware and in such other place or places as the Board of
Directors shall designate.
(g)
Shares of any series of the Series Preferred Stock which shall be issued and
thereafter acquired by the Corporation through purchase, redemption, conversion
or otherwise, shall return to the status of authorized but unissued shares
of
the Series Preferred Stock of the same series unless otherwise provided in
the
resolution or resolutions of the Board of Directors. Unless otherwise provided
in the resolution or resolutions of the Board of Directors providing for the
issuance thereof, the number of authorized shares of stock of any such series
may be increased or decreased (but not below the number of shares thereof then
outstanding nor in such manner as to exceed the number of shares authorized
in
Section Four) by resolution or resolutions of the Board of Directors and the
filing of a certificate complying with the requirements referred to in
subparagraph (f) above. In case the number of shares of any such series of
the
Series Preferred Stock shall be decreased, the shares representing such decrease
shall, unless otherwise provided in the resolution or resolutions of the Board
of Directors providing for the issuance thereof, resume the status of authorized
but unissued shares of the Series Preferred Stock, undesignated as to
series.
B.
Common Stock.
Subject
to the requirements of law, this Amended and Restated Certificate of
Incorporation, as amended from time to time, and the resolution or resolutions
of the Board of Directors creating or modifying any series of the Series
Preferred Stock, the holders of Common Stock shall (i) in the event of any
liquidation, dissolution or other winding up of the Corporation, whether
voluntary or involuntary, and after all holders of the Series Preferred Stock
shall have been paid in full the amounts to which they respectively shall be
entitled, be entitled to receive all the remaining assets of the Corporation
of
whatever kind, such assets to be distributed pro rata to the holders of the
Common Stock; and (ii) after payment in full of all dividends to which holders
of the Series Preferred Stock shall be entitled, be entitled to receive such
dividends as and when the same may be declared from time to time by the Board
of
Directors of the Corporation out of funds legally available
therefor.
Except
as
otherwise required by law and the provisions of this Amended and Restated
Certificate of Incorporation and except as provided by the resolution or
resolutions of the Board of Directors creating or amending any series of the
Series Preferred Stock, the holders of the Common Stock of the Corporation
possess full voting power for the election of Directors and for all other
purposes, and each holder thereof shall be entitled to one vote for each share
held by such holder.
FIVE:
Term.
The Corporation is to have perpetual existence.
SIX:
Board
of Directors.
(a)
All
corporate powers shall be exercised by or under the authority of, and the
business and affairs of the Corporation shall be managed under the direction
of,
a Board of Directors consisting of not less than three (3) nor more than ten
(10) persons. The exact number of Directors within the minimum and maximum
limitations specified in the preceding sentence shall be fixed from time to
time
by the Board of Directors pursuant to a resolution adopted by a majority of
the
entire Board of Directors.
(b)
Classified Board. The Board of Directors shall be divided into three classes,
each such class as nearly equal in number as the then-authorized number of
Directors constituting the Board of Directors permits, with the term of office
of one class expiring each year. Following approval of this Amended and Restated
Certificate of Incorporation, the stockholders shall elect the one class of
Directors for a term expiring at the annual meeting of stockholders to be held
in 2002, another class of Directors for a term expiring at the annual meeting
of
stockholders to be held in 2003, and another class of Directors for a term
expiring at the annual meeting of stockholders to be held in 2004. Thereafter,
each Director shall serve for a term ending at the third annual meeting of
stockholders of the Corporation following the annual meeting at which such
Director was elected. Members of each class shall hold office until their
successors are elected and qualified. At each succeeding annual meeting of
the
stockholders of the Corporation, the successors of the class of Directors whose
term expires at that meeting shall be elected by a plurality vote of all votes
cast at such meeting to hold office for a term expiring at the annual meeting
of
stockholders held in the third year following the year of their
election.
(c)
Vacancies. Subject to the rights of the holders of any Series Preferred Stock
then outstanding, newly created directorships resulting from any increase in
the
authorized number of Directors or any vacancies in the Board of Directors
resulting from death, resignation, retirement, disqualification, removal from
office or other cause shall be filled by a majority vote of the Directors then
in office, and Directors so chosen shall hold office for a term expiring at
the
annual meeting of stockholders at which the term of the class to which they
have
been elected expires. No decrease in the number of Directors constituting the
Board of Directors or amendment to this Certificate of Incorporation shall
shorten the term of any incumbent Director.
(d) Removal. Subject to the rights of the holders of any Series Preferred Stock
then outstanding, any Director, or the entire Board of Directors, may be removed
from office at any time, but only for cause and only by the affirmative vote
of
the holders of at least 662/3% of the voting power of all of the shares of
the
Corporation entitled to vote for the election of Directors.
SEVEN:
Director
Nomination Procedure; Annual Meeting Business.
(a)
Director Nomination Procedure. Nominations for the election of Directors may
be
made by the affirmative vote of a majority of the Board of Directors or a duly
authorized committee thereof or by any holder of record of shares of capital
stock of the Corporation entitled to vote generally for the election of
Directors; provided that any stockholder may nominate one or more persons for
election as Directors at a meeting only if written notice of such stockholder's
intention to make such nomination or nominations has been given, either by
personal delivery or by United States mail, postage prepaid, to the Secretary
of
the Corporation not later than (i) with respect to an election to be held at
an
annual meeting of stockholders, not less than ninety (90) days in advance of
such annual meeting if such annual meeting is to be held on or after the
one-year anniversary of the previous year's annual meeting, or for any other
annual meeting, on or before the later of (x) the close of business on the
fifteenth day following the date on which notice of the meeting is first given
to stockholders and (y) the date which is ninety (90) days before the date
of
such annual meeting, and (ii) with respect to an election to be held at a
special meeting of stockholders for the election of Directors, the close of
business on the seventh day following the date on which notice of the meeting
is
first given to stockholders. For the purposes of this paragraph (a) of this
Article SIX, the date notice of a meeting is deemed to have been first given
shall include, but not be limited to, the date on which disclosure of the date
of the meeting is first made in a press release reported by the Dow Jones News
Service, Associated Press or comparable national news service, or in a document
publicly filed by the Corporation with the Securities and Exchange Commission
pursuant to Section 13, 14 or 15(d) (or the rules and regulations thereunder)
of
the Securities Exchange Act of 1934, as amended. Each such notice to the
Secretary shall set forth the following information: (i) the name and address
of
record of the stockholder who intends to make the nomination, (ii) a
representation that the stockholder is a holder of record of stock of the
Corporation entitled to vote generally for the election of Directors at such
meeting and intends to appear in person or by proxy at the meeting to nominate
the person or persons specified in the notice, (iii) the name, age, business
and
residential addresses and principal occupation or employment of each nominee,
(iv) a description of all arrangements or understandings between the stockholder
and each proposed nominee and any other person or persons (naming such person
or
persons) pursuant to which the nomination or nominations are to be made by
the
stockholder, (v) such other information regarding each proposed nominee as
would
be required to be included in a proxy statement filed pursuant to the rules
and
regulations of the Securities and Exchange Commission and (vi) the written
consent of each proposed nominee to serve as a Director of the Corporation
if so
elected. The Corporation may require the proposed nominee to furnish such other
information as may reasonably be required by the Corporation to determine the
eligibility of such proposed nominee to serve as a Director of the Corporation.
The presiding officer of the meeting may, if the facts warrant, determine that
a
nomination was not made in accordance with the foregoing procedure, and if
such
officer should so determine, such officer shall so declare to the meeting and
the defective nomination shall be disregarded.
(b)
Annual Meeting Business. At an annual meeting of the stockholders, only such
business shall be conducted as shall have been properly brought before the
meeting. To be properly brought before an annual meeting, business must be
(i)
specified in the notice of meeting (or any supplement thereto) given by or
at
the direction of the Board of Directors, (ii) otherwise properly brought before
the meeting by or at the direction of the Board of Directors or (iii) otherwise
properly brought before the meeting by a stockholder. For business to be
properly brought before an annual meeting by a stockholder, the stockholder
must
have given timely notice thereof in writing to the Secretary of the Corporation.
To be timely, a stockholder's notice must be received at the principal executive
offices of the Corporation (i) not less than ninety (90) days in advance of
a
meeting if such meeting is to be held on or after the one-year anniversary
of
the previous year's annual meeting, and (ii) with respect to any other annual
meeting of stockholders, the later of (x) the close of business on the fifteenth
day following the date on which notice of the meeting is first given to
stockholders and (y) the date which is ninety (90) days before the date of
such
annual meeting.
For
the
purposes of this paragraph (b) of this Article SEVEN, the date of public
disclosure of a meeting shall include, but not be limited to, the date on which
disclosure of the date of the meeting is first made in a press release reported
by the Dow Jones News Service, Associated Press or comparable national news
service, or in a document publicly filed by the Corporation with the Securities
and Exchange Commission pursuant to Section 13, 14 or 15(d) (or the rules and
regulations thereunder) of the Securities Exchange Act of 1934, as amended.
A
stockholder's notice to the Secretary of the Corporation shall set forth as
to
each matter the stockholder proposes to bring before the annual meeting (i)
a
brief description of the business desired to be brought before the annual
meeting and the reasons for conducting such business at the annual meeting,
(ii)
the name, age and business and residential addresses, as they appear on the
Corporation's records, of the stockholder proposing such business, (iii) the
class and number of shares of the Corporation which are beneficially owned
by
the stockholder and (iv) any material interest of the stockholder in such
business. Notwithstanding anything in the Bylaws of the Corporation to the
contrary, no business shall be conducted at an annual meeting except in
accordance with the procedures set forth herein. The Chairman of the annual
meeting shall, if the facts warrant, determine and declare to the meeting that
business was not properly brought before the meeting and in accordance with
the
provisions hereof, and if the Chairman should so determine, the Chairman shall
so declare to the meeting and any such business not properly brought before
the
meeting shall not be transacted.
EIGHT:
By-laws. In furtherance and not in limitation of the powers conferred by
statute, and except as otherwise provided herein or in the By-laws of the
Corporation, the Board of Directors is expressly authorized to make, alter
or
repeal the By-laws of the Corporation by a 66 2/3% vote of
Directors.
NINE:
Meetings. Special meetings of stockholders, for any purpose or purposes, unless
otherwise prescribed by statute, may be called by the Chairman of the Board
or
by the Board of Directors pursuant to a resolution adopted by a majority of
the
total number of Directors which the Corporation would have if there were no
vacancies, and such special meeting may not be called by any other person or
persons.
TEN:
Limitation on Actions by Consent. No action required to be taken or which may
be
taken at any annual or special meeting of stockholders of the Corporation may
be
taken by written consent without a meeting, except that any such action may
be
taken without prior notice and without a vote, if a consent in writing, setting
forth that action so taken shall be signed by all the stockholders of the
Corporation entitled to vote thereon.
ELEVEN:
Indemnification. The Directors of the Corporation shall be protected from
personal liability, through indemnification or otherwise, to the fullest extent
permitted under the General Corporation Law of the State of Delaware as from
time to time in effect.
(a)
A
Director of the Corporation shall under no circumstances have any personal
liability to the Corporation or its stockholders for monetary damages for breach
of fiduciary duty as a Director except for those breaches and acts or omissions
with respect to which the General Corporation Law of the State of Delaware,
as
from time to time amended, expressly provides that this provision shall not
eliminate or limit such personal liability of Directors. Neither the
modification or repeal of this paragraph (a) of Article ELEVEN nor any amendment
to said General Corporation Law that does not have retroactive application
shall
limit the right of Directors hereunder to exculpation from personal liability
for any act or omission occurring prior to such amendment, modification or
repeal.
(b)
The
Corporation shall indemnify each Director and Officer of the Corporation to
the
fullest extent permitted by applicable law, except as may be otherwise provided
in the Corporation's By-laws, and in furtherance hereof the Board of Directors
is expressly authorized to amend the Corporation's By-laws from time to time
to
give full effect hereto, notwithstanding possible self interest of the Directors
in the action being taken. Neither the modification or repeal of this paragraph
(b) of Article ELEVEN nor any amendment to the General Corporation Law of the
State of Delaware that does not have retroactive application shall limit the
right of Directors and Officers to indemnification hereunder with respect to
any
act or omission occurring prior to such modification, amendment or
repeal.
TWELVE:
Amendments. The Corporation reserves the right to amend, alter, change or repeal
any provision contained in this Amended and Restated Certificate of
Incorporation in the manner now or hereafter prescribed by statute, and all
rights conferred upon stockholders herein are granted subject to this
reservation. Notwithstanding anything to the contrary set forth herein, Articles
SIX,
SEVEN, EIGHT, NINE, TEN
and this
Article TWELVE
may not
be amended without the affirmative vote of shareholders holdings shares
representing 66 2/3% of the votes entitled to be cast in respect
thereof.
IN
WITNESS WHEREOF, the Corporation has caused this Amended and Restated
Certificate to be duly executed this [__] day of [_______], 2006.
|
_____________________________
By:
|
|
Title:
|
APPENDIX
B
eMAGIN
CORPORATION
AMENDED
AND RESTATED
2004
NON-EMPLOYEE COMPENSATION PLAN
This
eMagin Corporation 2004
AMENDED AND RESTATED NON-EMPLOYEE COMPENSATION PLAN
(the "
Plan
") is
designed to retain outside consultants, professionals and service providers
and
reward them for making major contributions to the success of the Company. These
objectives are accomplished by making long-term incentive awards under the
Plan
thereby providing Participants with a proprietary interest in the growth and
performance of the Company.
(a)
|
"
Board
"
- The Board of Directors of the
Company.
|
(b)
|
"
Code
"
- The Internal Revenue Code of 1986, as amended from time to
time.
|
(c)
|
"
Committee
"
- The Compensation Committee of the Company's Board, or such other
committee of the Board that is designated by the Board to administer
the
Plan, composed of not less than two members of the Board all of whom
are
disinterested persons, as contemplated by Rule 16b-3 (" Rule
16b-3
")
promulgated under the Securities Exchange Act of 1934, as amended
(the "
Exchange
Act
").
|
(d)
|
"
Company
"
- eMagin Corporation and its subsidiaries including subsidiaries
of
subsidiaries.
|
(e)
|
"
Exchange Act
"
- The Securities Exchange Act of 1934, as amended from time to
time.
|
(f)
|
"
Fair
Market Value
"
- The fair market value of the Company's issued and outstanding Stock
as
determined in good faith by the Board or
Committee.
|
(g)
|
"
Grant
"
- The grant of any stock award to a Participant pursuant to such
terms,
conditions and limitations as the Committee may establish in order
to
fulfill the objectives of the Plan.
|
(h)
|
"
Grant
Agreement
"
- An agreement between the Company and a Participant that sets forth
the
terms, conditions and limitations applicable to a
Grant.
|
(i)
|
"
Participant
"
- An outside consultants, professional and service provider of the
Company
to whom an Award has been made under the
Plan.
|
(j)
|
"
Securities
Act
"
- The Securities Act of 1933, as amended from time to
time.
|
(k)
|
"
Stock
"
- Authorized and issued or unissued shares of common stock of the
Company.
|
(l)
|
"
Stock
Award
"
- A Grant made under the Plan in stock or denominated in units of
stock
for which the Participant is not obligated to pay additional
consideration.
|
2.
|
Administration.
The
Plan shall be administered by the Board, provided however, that
the Board
may delegate such administration to the Committee. Subject to the
provisions of the Plan, the Board and/or the Committee shall have
authority to (a) grant, in its discretion, Stock Awards; (b) determine
in
good faith the fair market value of the Stock covered by any Grant;
(c)
determine which eligible persons shall receive Grants and the number
of
shares, restrictions, terms and conditions to be included in such
Grants;
(d) construe and interpret the Plan; (e) promulgate, amend and
rescind
rules and regulations relating to its administration, and correct
defects,
omissions and inconsistencies in the Plan or any Grant; (f) consistent
with the Plan and with the consent of the Participant, as appropriate,
amend any outstanding Grant; (g) determine the duration and purpose
of
leaves of absence which may be granted to Participants without
constituting termination of their engagement for the purpose of
the Plan
or any Grant; and (h) make all other determinations necessary or
advisable
for the Plan's administration. The interpretation and construction
by the
Board of any provisions of the Plan or selection of Participants
shall be
conclusive and final. No member of the Board or the Committee shall
be
liable for any action or determination made in good faith with
respect to
the Plan or any Grant made
thereunder.
|
3.
|
Eligibility.
The
persons who shall be eligible to receive Grants shall be outside
consultants, professionals and service providers who provide services
to
the Company in connection with, among other things, the Company’s
obligations as a publicly-held reporting company. The term consultant
shall mean any person, other than an employee, who is engaged by
the
Company to render services and is compensated for such
services.
|
Authorized
Stock:
Stock
subject to Grants may be either unissued or reacquired Stock.
(a)
|
Number
of Shares:
Subject to adjustment as provided in Section 5(i) of the Plan, the
total
number of shares of Stock which may be purchased or granted directly
by
Stock Awards granted under the Plan shall not exceed Nine Million
Five
Hundred Thousand (9,500,000) shares. If any Grant shall for any reason
terminate or expire, any shares allocated thereto but remaining unvested
shall again be available for Grants with respect thereto under the
Plan as
though no Grant had previously occurred with respect to such shares.
Any
shares of Stock issued pursuant to a Grant and repurchased pursuant
to the
terms thereof shall be available for future Grants as though not
previously covered by a Grant.
|
(b)
|
Reservation
of Shares:
The Company shall reserve and keep available at all times during
the term
of the Plan such number of shares as shall be sufficient to satisfy
the
requirements of the Plan. If, after reasonable efforts, which efforts
shall not include the registration of the Plan or Grants under the
Securities Act, the Company is unable to obtain authority from any
applicable regulatory body, which authorization is deemed necessary
by
legal counsel for the Company for the lawful issuance of shares hereunder,
the Company shall be relieved of any liability with respect to its
failure
to issue and sell the shares for which such requisite authority was
so
deemed necessary unless and until such authority is
obtained.
|
5.
|
Stock
Awards.
All
or part of any Stock Award under the Plan may be subject to conditions
established by the Board or the Committee, and set forth in a Stock
Award
Agreement, which may include, but are not limited to, continuous
service
with the Company, achievement of specific business objectives,
increases
in specified indices, attaining growth rates and other comparable
measurements of Company performance. Such Awards may be based on
Fair
Market Value or other specified valuation. All Stock Awards will
be made
pursuant to the execution of a Stock Award
Agreement.
|
(a)
|
Conditions
and Restrictions.
Shares of Stock which Participants may receive as a Stock Award under
a
Stock Award Agreement may include such restrictions as the Board
or
Committee, as applicable, shall determine, including restrictions
on
transfer, repurchase rights, right of first refusal, and forfeiture
provisions. When transfer of Stock is so restricted or subject to
forfeiture provisions it is referred to as " Restricted
Stock.
"
Further, with Board or Committee approval, Stock Awards may be deferred,
either in the form of installments or a future lump sum distribution.
The
Board or Committee may permit selected Participants to elect to defer
distributions of Stock Awards in accordance with procedures established
by
the Board or Committee to assure that such deferrals comply with
applicable requirements of the Code including, at the choice of
Participants, the capability to make further deferrals for distribution
after retirement. Any deferred distribution, whether elected by the
Participant or specified by the Stock Award Agreement or by the Board
or
Committee, may require the payment be forfeited in accordance with
the
provisions of Section 5(c). Dividends or dividend equivalent rights
may be
extended to and made part of any Stock Award, subject to such terms,
conditions and restrictions as the Board or Committee may
establish.
|
(b)
|
Cancellation
and Rescission of Grants.
Unless the Stock Award Agreement specifies otherwise, the Board or
Committee, as applicable, may cancel any unvested or deferred Grants
at
any time if the Participant is not in compliance with all other applicable
provisions of the Stock Award Agreement, the Plan and with the following
conditions:
|
(i)
|
A
Participant shall not render services for any organization or engage
directly or indirectly in any business which, in the judgment of
the chief
executive officer of the Company or other senior officer designated
by the
Board or Committee, is or becomes competitive with the Company, or
which
organization or business, or the rendering of services to such
organization or business, is or becomes otherwise prejudicial to
or in
conflict with the interests of the Company. For Participants whose
engagement has terminated, the judgment of the chief executive officer
shall be based on the Participant's position and responsibilities
while
employed by the Company, the Participant's post-engagement
responsibilities and position with the other organization or business,
the
extent of past, current and potential competition or conflict between
the
Company and the other organization or business, the effect on the
Company's customers, suppliers and competitors and such other
considerations as are deemed relevant given the applicable facts
and
circumstances. A Participant who has retired shall be free, however,
to
purchase as an investment or otherwise, stock or other securities
of such
organization or business so long as they are listed upon a recognized
securities exchange or traded over-the-counter, and such investment
does
not represent a substantial investment to the Participant or a greater
than five percent (5%) equity interest in the organization or
business.
|
(ii)
|
A
Participant shall not, without prior written authorization from the
Company, disclose to anyone outside the Company, or use in other
than the
Company's business, any confidential information or material relating
to
the business of the Company, acquired by the Participant either during
or
after engagement with the Company.
|
(iii)
|
A
Participant shall disclose promptly and assign to the Company all
right,
title and interest in any invention or idea, patentable or not, made
or
conceived by the Participant during engagement by the Company, relating
in
any manner to the actual or anticipated business, research or development
work of the Company and shall do anything reasonably necessary to
enable
the Company to secure a patent where appropriate in the United States
and
in foreign countries
|
(iv)
|
Upon
exercise, payment or delivery pursuant to a Grant, the Participant
shall
certify on a form acceptable to the Company that he or she is in
compliance with the terms and conditions of the
Plan.
|
(i)
|
Except
pursuant to Section 5(e)(iii) and except as set forth in Section
5(d)(ii),
no Grant or any other benefit under the Plan shall be assignable
or
transferable, or payable to, anyone other than the Participant to
whom it
was granted..
|
(ii)
|
Where
a Participant terminates engagement and retains a Grant pursuant
to
Section 5(e)(ii) in order to assume a position with a governmental,
charitable or educational institution, the Board or Committee, in
its
discretion and to the extent permitted by law, may authorize a third
party
(including but not limited to the trustee of a "blind" trust), acceptable
to the applicable governmental or institutional authorities, the
Participant and the Board or Committee, to act on behalf of the
Participant with regard to such
Awards.
|
(d)
|
Termination
of Engagement.
If
the engagement or service to the Company of a Participant terminates,
other than pursuant to any of the following provisions under this
Section
5(e), all unvested or deferred Stock Awards shall be cancelled
immediately, unless the Stock Award Agreement provides
otherwise:
|
(i)
|
Retirement
Under a Company Retirement Plan.
When a Participant's engagement terminates as a result of retirement
in
accordance with the terms of a Company retirement plan, the Board
or
Committee may permit Stock Awards to continue in effect beyond the
date of
retirement in accordance with the applicable Grant Agreement and
vesting
of any such Grants may be
accelerated.
|
(ii)
|
Rights
in the Best Interests of the Company.
When a Participant resigns from the Company and, in the judgment
of the
Board or Committee, the acceleration and/or continuation of outstanding
Stock Awards would be in the best interests of the Company, the Board
or
Committee may (i) authorize, where appropriate, the acceleration
and/or
continuation of all or any part of Grants issued prior to such termination
and (ii) permit the vesting of such Grants for such period as may
be set
forth in the applicable Grant Agreement, subject to earlier cancellation
pursuant to Section 8 or at such time as the Board or Committee shall
deem
the continuation of all or any part of the Participant's Grants are
not in
the Company's best interest.
|
(iii)
|
Death
or Disability of a Participant
|
(1)
|
In
the event of a Participant's death, the Participant's estate or
beneficiaries shall have a period up to the expiration date specified
in
the Grant Agreement within which to receive or exercise any outstanding
Grant held by the Participant under such terms as may be specified
in the
applicable Grant Agreement. Rights to any such outstanding Grants
shall
pass by will or the laws of descent and distribution in the following
order: (a) to beneficiaries so designated by the Participant; if
none,
then (b) to a legal representative of the Participant; if none, then
(c)
to the persons entitled thereto as determined by a court of competent
jurisdiction. Grants so passing shall be made at such times and in
such
manner as if the Participant were
living.
|
(2)
|
In
the event a Participant is deemed by the Board or Committee to be
unable
to perform his or her usual duties by reason of mental disorder or
medical
condition which does not result from facts which would be grounds
for
termination for cause, Grants and rights to any such Grants may be
paid to
the Participant, if legally competent, or a committee or other legally
designated guardian or representative if the Participant is legally
incompetent by virtue of such
disability.
|
(3)
|
After
the death or disability of a Participant, the Board or Committee
may in
its sole discretion at any time (1) terminate restrictions in Grant
Agreements; (2) accelerate any or all installments and rights; and
(3)
instruct the Company to pay the total of any accelerated payments
in a
lump sum to the Participant, the Participant's estate, beneficiaries
or
representative; notwithstanding that, in the absence of such termination
of restrictions or acceleration of payments, any or all of the payments
due under the Grant might ultimately have become payable to other
beneficiaries.
|
(4)
|
In
the event of uncertainty as to interpretation of or controversies
concerning this Section 5, the determinations of the Board or Committee,
as applicable, shall be binding and
conclusive.
|
6.
|
Investment
Intent.
All
Grants under the Plan are intended to be exempt from registration
under
the Securities Act provided by Rule 701 thereunder. Unless and
until the
sale and issuance of Stock subject to the Plan are registered under
the
Securities Act or shall be exempt pursuant to the rules promulgated
thereunder, each Grant under the Plan shall provide that the purchases
or
other acquisitions of Stock thereunder shall be for investment
purposes
and not with a view to, or for resale in connection with, any distribution
thereof. Further, unless the issuance and sale of the Stock have
been
registered under the Securities Act, each Grant shall provide that
no
shares shall be purchased upon the exercise of the rights under
such Grant
unless and until (i) all then applicable requirements of state
and federal
laws and regulatory agencies shall have been fully complied with
to the
satisfaction of the Company and its counsel, and (ii) if requested
to do
so by the Company, the person exercising the rights under the Grant
shall
(i) give written assurances as to knowledge and experience of such
person
(or a representative employed by such person) in financial and
business
matters and the ability of such person (or representative) to evaluate
the
merits and risks of receiving the Stock as compensation, and (ii)
execute
and deliver to the Company a letter of investment intent and/or
such other
form related to applicable exemptions from registration, all in
such form
and substance as the Company may require. If shares are issued
upon
exercise of any rights under a Grant without registration under
the
Securities Act, subsequent registration of such shares shall relieve
the
purchaser thereof of any investment restrictions or representations
made
upon the exercise of such
rights.
|
7.
|
Amendment,
Modification, Suspension or Discontinuance of the
Plan
.
The
Board may, insofar as permitted by law, from time to time, with
respect to
any shares at the time not subject to outstanding Grants, suspend
or
terminate the Plan or revise or amend it in any respect whatsoever,
except
that without the approval of the shareholders of the Company, no
such
revision or amendment shall (i) increase the number of shares subject
to
the Plan, (ii) decrease the price at which Grants may be granted,
(iii)
materially increase the benefits to Participants, or (iv) change
the class
of persons eligible to receive Grants under the Plan; provided,
however,
no such action shall alter or impair the rights and obligations
under any
Stock Award outstanding as of the date thereof without the written
consent
of the Participant thereunder. No Grant may be issued while the
Plan is
suspended or after it is terminated, but the rights and obligations
under
any Grant issued while the Plan is in effect shall not be impaired
by
suspension or termination of the Plan.
In
the event of any change in the outstanding Stock by reason of
a stock
split, stock dividend, combination or reclassification of shares,
recapitalization, merger, or similar event, the Board or the
Committee may
adjust proportionally (a) the number of shares of Stock (i) reserved
under
the Plan, (ii) covered by outstanding Stock Awards; (b) the Stock
prices
related to outstanding Grants; and (c) the appropriate Fair Market
Value
and other price determinations for such Grants. In the event
of any other
change affecting the Stock or any distribution (other than normal
cash
dividends) to holders of Stock, such adjustments as may be deemed
equitable by the Board or the Committee, including adjustments
to avoid
fractional shares, shall be made to give proper effect to such
event. In
the event of a corporate merger, consolidation, acquisition of
property or
stock, separation, reorganization or liquidation, the Board or
the
Committee shall be authorized to issue or assume stock options,
whether or
not in a transaction to which Section 424(a) of the Code applies,
and
other Grants by means of substitution of new Grant Agreements
for
previously issued Grants or an assumption of previously issued
Grants.
|
8.
|
Tax
Withholding.
The
Company shall have the right to deduct applicable taxes from any
Grant
payment and withhold, at the time of delivery or exercise of Stock
Awards
or vesting of shares under such Grants, an appropriate number of
shares
for payment of taxes required by law or to take such other action
as may
be necessary in the opinion of the Company to satisfy all obligations
for
withholding of such taxes. If Stock is used to satisfy tax withholding,
such stock shall be valued based on the Fair Market Value when
the tax
withholding is required to be
made.
|
9.
|
Availability
of Information
.
During
the term of the Plan and any additional period during which a Grant
granted pursuant to the Plan shall be payable, the Company shall
make
available, not later than one hundred and twenty (120) days following
the
close of each of its fiscal years, such financial and other information
regarding the Company as is required by the bylaws of the Company
and
applicable law to be furnished in an annual report to the shareholders
of
the Company.
|
10.
|
Notice.
Any
written notice to the Company required by any of the provisions
of the
Plan shall be addressed to the chief personnel officer or to the
chief
executive officer of the Company, and shall become effective when
it is
received by the office of the chief personnel officer or the chief
executive officer.
|
11.
|
Indemnification
of Board.
In
addition to such other rights or indemnifications as they may have
as
directors or otherwise, and to the extent allowed by applicable
law, the
members of the Board and the Committee shall be indemnified by
the Company
against the reasonable expenses, including attorneys' fees, actually
and
necessarily incurred in connection with the defense of any claim,
action,
suit or proceeding, or in connection with any appeal thereof, to
which
they or any of them may be a party by reason of any action taken,
or
failure to act, under or in connection with the Plan or any Grant
granted
thereunder, and against all amounts paid by them in settlement
thereof
(provided such settlement is approved by independent legal counsel
selected by the Company) or paid by them in satisfaction of a judgment
in
any such claim, action, suit or proceeding, except in any case
in relation
to matters as to which it shall be adjudged in such claim, action,
suit or
proceeding that such Board or Committee member is liable for negligence
or
misconduct in the performance of his or her duties; provided that
within
sixty (60) days after institution of any such action, suit or Board
proceeding the member involved shall offer the Company, in writing,
the
opportunity, at its own expense, to handle and defend the
same.
|
12.
|
Governing
Law.
The
Plan and all determinations made and actions taken pursuant hereto,
to the
extent not otherwise governed by the Code or the securities laws
of the
United States, shall be governed by the law of the State of Delaware
and
construed accordingly.
|
13.
|
Effective
and Termination Dates.
The
Plan shall become effective on the date it is approved by the holders
of a
majority of the shares of Stock then outstanding. The Plan shall
terminate
ten years later, subject to earlier termination by the Board pursuant
to
Section 7.
|
The
foregoing 2004 AMENDED AND RESTATED NON-EMPLOYEE COMPENSATION PLAN (consisting
of 7 pages, including this page) was duly adopted and approved by the Board
of
Directors on _________, 2006 .
|
|
|
|
eMAGIN
CORPORATION
a
Delaware corporation
|
|
|
|
_____________________________
By:
|
|
Title:
|
eMAGIN
CORPORATION
PROXY
FOR ANNUAL MEETING TO BE HELD ON OCTOBER 20, 2006
THIS
PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The
undersigned hereby appoints Gary W. Jones, as proxy, with the power to appoint
his substitute, to represent and to vote all the shares of common stock of
eMagin Corporation (the "Company"), which the undersigned would be entitled
to
vote, at the Company's Annual Meeting of Stockholders to be held on October
20,
2006 and at any adjournments thereof, subject to the directions indicated on
the
reverse side hereof.
In
their
discretion, the proxy is authorized to vote upon any other matter that may
properly come before the meeting or any adjournments thereof.
THIS
PROXY WILL BE VOTED IN ACCORDANCE WITH THE SPECIFICATIONS MADE, BUT IF NO
CHOICES ARE INDICATED, THIS PROXY WILL BE VOTED FOR THE ELECTION OF ALL NOMINEES
AND FOR THE PROPOSALS LISTED ON THE REVERSE SIDE.
IMPORTANT--This
Proxy must be signed and dated on the reverse side.
___________________________________________________________________
THIS
IS YOUR PROXY
YOUR
VOTE IS IMPORTANT!
Dear
Stockholder:
We
cordially invite you to attend the Annual Meeting of Stockholders of eMagin
Corporation to be tentatively held at the Hyatt Bellevue, 900 Bellevue Way
N.E.,
Bellevue, Washington, 98004, on Wednesday, October 20, 2006, at 2:00 pm local
time.
Please
read the proxy statement which describes the proposals and presents other
important information, and complete, sign and return your proxy promptly in
the
enclosed envelope.
TELEPHONE
VOTING
|
|
INTERNET
VOTING
|
|
VOTING
BY MAIL
|
This
method of voting is available for residents of the U.S. and Canada.
On a
touch tone telephone, call TOLL
FREE 1-800-790-3272,
24 hours a day, 7 days a week. You will be asked to enter ONLY
the CONTROL NUMBER shown below. Have you proxy card ready, then follow
the
prerecorded instructions. Your vote will be confirmed and cast as
you
directed. Available 24 hours a day, 7 days a week until 5:00 p.m.
Eastern
time on October 19, 2006.
|
|
Visit
the Internet voting website at http://proxy.georgeson.com.
Enter the COMPANY NUMBER and
CONTROL NUMBER shown below and follow the instructions on your screen.
You
will incur only your usual Internet charges. Available 24 hours a
day, 7
days a week until 5:00 p.m. Eastern time on October 19,
2006.
|
|
Simply
mark, sign and date your proxy card and return it in the postage-paid
envelope. If you are voting by telephone or the Internet, please
do not
mail your proxy card.
|
DO
NOT RETURN YOUR PROXY CARD IF YOU ARE VOTING BY TELEPHONE OR
INTERNET.
CALL
**TOLL-FREE** 1-800-790-3272 ON A TOUCH-TONE TELEPHONE -
ANYTIME.
There
is no charge to you for this call.
COMPANY
NUMBER
|
|
CONTROL
NUMBER
|
TO
VOTE
BY MAIL, PLEASE DETACH PROXY CARD HERE
---------------------------------------------------------------------------------------------------------------------------
THE
BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSALS 1-6
1.
Election of Directors
Nominees:
|
|
|
|
Class
B
|
FOR
|
WITHHOLD
|
|
Paul Cronson
|
[_]
|
[_]
|
|
Thomas Paulsen
|
[_]
|
[_]
|
|
Stephen Seay
|
[_]
|
[_]
|
|
--------------------------------------------------------------------------------
(Except
nominee(s) written above)
|
2.
Proposal to increase the maximum number of directors which may be
appointed to the Company’s Board of Directors from 9 to 10
persons.
|
FOR
|
AGAINST
|
ABSTAIN
|
|
FOR
|
AGAINST
|
ABSTAIN
|
3.
Proposal to effectuate the one-for-ten reverse stock split
|
[_]
|
[_]
|
[_]
|
|
FOR
|
AGAINST
|
ABSTAIN
|
4.
Proposal to approve of the potential issuance of shares of our common
stock at a price below fair market value.
|
[_]
|
[_]
|
[_]
|
|
FOR
|
AGAINST
|
ABSTAIN
|
5.
Proposal to increase the number of authorized shares of common stock
issuable pursuant to the 2004 Non-Employee Stock Compensation Plan
from
2,000,000 to 9,500,000 shares
|
[_]
|
[_]
|
[_]
|
|
FOR
|
AGAINST
|
ABSTAIN
|
6.
Proposal to ratify Eisner LLP as the Company’s independent auditors for
fiscal year 2006
|
[_]
|
[_]
|
[_]
|
|
|
|
|
|
|
|
|
|
|
|
|
To
sign up for electronic voting please mark this box
|
[__]
|
If
you plan to attend the Annual Meeting please mark this box
|
[__]
|
|
|
If
you would like to receive eMagin email Alerts about eMagin financial
filings as well as company news and other activities please mark
this box
or register online at http://ir.emagin.com
|
[__]
|
Dated:________________,
2006
Signature
______________________________________________________________________
Name
(printed) _________________________________________________________________
Title
__________________________________________________________________________
Important:
Please sign exactly as name appears on this proxy. When signing as attorney,
executor, trustee, guardian, corporate officer, etc., please indicate full
title.
45